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Background: Resident macrophages (Mϕs) are distributed 
throughout the body and are important for maintaining tissue 
homeostasis and for defence against infections. Tissue Mϕs are highly 
adapted to their microenvironment and thought to mediate tissue-
specific functions involving metabolism and immune defence that are 
not fully elucidated.  
Methods: We have used high resolution quantitative proteomics to 
gain insights into the functions of two types of resident tissue Mϕs: 
peritoneal cavity Mϕs and splenic red pulp Mϕs.  The cellular 
expression levels of many proteins were validated by flow cytometry 
and were consistently in agreement with the proteomics data. 
Results: Peritoneal and splenic red pulp macrophages displayed 
major differences in cell surface phenotype reflecting their adaptation 
to different tissue microenvironments and tissue-specific functions. 
Peritoneal Mϕs were shown to be enriched in a number of key 
enzymes and metabolic pathways normally associated with the liver, 
such as metabolism of fructose, detoxification, nitrogen homeostasis 
and the urea cycle. Supporting these observations, we show that 
peritoneal Mϕs are able to utilise glutamine and glutamate which are 
rich in peritoneum for urea generation.  In comparison, splenic red 
pulp Mϕs were enriched in proteins important for adaptive immunity 
such as antigen presenting MHC molecules, in addition to proteins 
required for erythrocyte homeostasis and iron turnover. We also show 
that these tissue Mϕs may utilise carbon and nitrogen substrates for 
different metabolic fates to support distinct tissue-specific roles. 
Conclusions: This study provides new insights into the functions of 
tissue Mϕs in immunity and homeostasis.  The comprehensive 
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proteomics data sets are a valuable resource for biologists and 
immunologists.
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Introduction
Resident macrophages (Mϕs) are distributed in tissues throughout 
the body and contribute to both homeostasis and defence against 
infectious disease. Resident Mϕs from different tissues are highly 
heterogeneous in properties and functions and this is reflected 
in considerable diversity in their transcriptomes1. Tissue Mϕs 
arise from both embryonic and adult sources including yolk sac, 
foetal liver and bone marrow and recent studies have shown that 
local signalling within tissues is sufficient to promote the acqui-
sition of specialized Mϕ functions irrespective of their tissue of 
origin2. Therefore, tissue Mϕs have distinct phenotypic and met-
abolic characteristics that define tissue-specific functions and 
unique roles, even at steady-state. The detailed molecular charac-
terisation of tissue Mϕs is important in order to fully understand 
the various roles they play in a given tissue.
Important insights into Mϕ functions have been gained 
by system-wide analyses of transcriptional regulation and 
epigenetics1,3,4. However, much less is known about protein 
dynamics. The proteome can differ significantly from the tran-
scriptome due to a variety of regulatory processes such as post- 
transcriptional processing and degradation of mRNA and 
protein modifications and degradation, all of which are important 
in controlling steady-state protein abundance. Recent technologi-
cal advances in mass spectrometry (MS) permit the systematic 
quantification of thousands of proteins from cellular lysates5.
Proteomics data, when combined with complementary 
approaches, such as bioinformatics and pathway data analysis 
tools, provides the contextual information required to decode large 
data sets into meaningful biologically adaptive processes such 
as cellular functions and metabolic pathways.
Tissue Mϕs can be divided into two categories: those that are 
‘fixed’ within the tissue by being firmly embedded in 
neighbouring stroma and those that are ‘free’ to migrate within 
tissues. To investigate tissue Mϕ proteomes of each category, we 
selected splenic red pulp Mϕs (SRPM) as an example of fixed 
Mϕs and peritoneal cavity Mϕs (PM) as an example of free 
Mϕs6. Both of these Mϕ populations are embryo-derived and 
have some well-known functions. SRPM are important for 
clearance of aged red blood cells, and iron homeostasis and 
recycling from senescent and damaged erythrocytes2,7–9. 
In contrast, PM play a role in B1 cell class switching and 
through their ability to rapidly migrate into visceral organs, 
they have been shown to play role in tissue repair and liver 
regeneration10–15.
To characterise and investigate other possible tissue-specific 
functions for SRPM and PM at steady-state, we used MS 
approaches to obtain accurate quantification of protein copy 
number per cell that was validated by flow cytometry. Com-
parisons of the proteomes with the corresponding transcrip-
tomes were made using the ImmGen16 gene expression database, 
which provided high-throughput validation for the translation of 
mRNA to protein for many of the differentially expressed genes 
and also revealed numerous examples of discordance between 
mRNA and protein levels. We have combined proteomics with 
complementary approaches, decoded large data sets and revealed 
novel functions relating to metabolism and host defence, in 
addition to previously characterised functions.
Methods
Reagents and antibodies
Dulbecco’s phosphate buffered saline (PBS) without 
Ca & Mg, Foetal Bovine Serum (FBS) (qualified, heat inactivated, 
E.U.-approved), Pen-Strep, Trypsin-EDTA solution, Microplate 
BCA Protein Assay, sample reducing agent, trypsin protease, 
Pierce -MS Grade, Roche-COMPLETE Mini EDTA-Free Protease 
Inhibitor tablets, Roche-PHOSS-RO, PhosSTOP™ Trypan blue 
solution were from Sigma, UK; CD16/CD32 (Fc-receptor block), 
V500 anti-mouse I-A/I E antibody (clone: M5/114; Cat# 562366) 
and PE anti-mouse Siglec-F antibody Cat# 552126 were from 
BD Bioscience, UK; Alexa Fluor 488 anti-mouse CD11b antibody 
(M1/70) Cat# 53-0112-82, PE-cy7 anti-mouse CD11c antibody 
(Clone: N418) Cat# 25-0114-82, PE anti-mouse CD163 antibody 
(TNKUPJ) Cat# 12-1631-80 were from ThermoS eBioscience™, 
UK; FITC anti-human/mouse CD49f (ITGA6) antibody 
Cat# 313605, PE anti-mouse CD51 ITGAV antibody Cat# 104105, 
Alexa Fluor® 488 anti-mouse CD31 (pecam-1) antibody Cat# 
102413, FITC anti-mouse CD66a (CEACAM1a) antibody 
Cat# 134517, Alexa Fluor® 488 anti-mouse CD102 (ICAM2) anti-
body Cat# 105609, Alexa Fluor® 488 anti-mouse CD54 (icam1) 
antibody Cat# 116111, FITC anti-mouse CD200R (OX2R) anti-
body Cat# 123909, FITC anti-mouse CD244.2 antibody Cat# 
133503, FITC anti-mouse CD20 antibody Cat# 150407, PE 
anti-mouse CD282 (TLR2) antibody Cat# 148603, Alexa Fluor® 
488 anti-mouse CD172a (SIRPα) antibody Cat# 144023, Alexa 
Fluor® 488 anti-mouse F4/80 antibody Cat# 123119, FITC anti-
mouse/human CD44 antibody Cat# 103021, APC anti-mouse 
F4/80 antibody Cat# 123116, APC anti-mouse CD106 anti-
body Cat# 105717, PE anti-mouse CD80 antibody (16-10A1 ) 
Cat# 104707, PE anti-mouse CD86 (B7-2) antibody Cat# 
12-0862-82, APC anti-mouse Tim-4 antibody Cat# 130010, 
PE/Cy7 anti-mouse TLR4 antibody Cat# 117609 were from 
Biolegend, UK.
Animals
C57BL/6J wildtype mice were used throughout. All 60 mice 
used in the study were maintained in the Biological Resource 
Unit at the University of Dundee under specific-pathogen-free 
conditions following procedures that were approved by the Uni-
versity of Dundee Ethical Committee and under the authoriza-
tion of the UK Home Office Animals (Scientific Procedures) Act 
1986. Mice were housed in same sex groups, in individually ven-
tilated cages and were given standard diet RM3 (SDS Special 
Diet Services). Housing conditions were: 12-h light, 12-h dark 
cycle, 21°C temperature and relative humidity of 45–60%. Mice 
had free access to autoclaved drinking water and autoclaved 
food ad libitum. Mice were humanely killed using a Schedule 1 
method of gradual exposure to carbon dioxide and death was 
confirmed by cervical dislocation.
SRPM isolation and purification
SRPM were purified as described previously17. In brief, single 
cell suspensions of splenocytes were obtained by digesting the 
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tissue with 400 U/ml collagenase D and 50 μg/ml DNAse 1 at 
37°C for 20 minutes, erythrocytes were lysed and passed through 
a 100 μm cell strainer following suspension in MACS buffer. 
The single cell suspensions of splenocytes were then passed 
over LS separation columns (Miltenyi) without further 
treatment. Before being removed from the magnet, the columns 
were washed three times with 2 ml MACS buffer (Miltenyi). 
After removal of the magnet, SRPM were eluted from the 
separation column with 5 ml MACS buffer and subjected to 
fluorescence activated cell sorting.
PM Isolation and purification
The peritoneal cavity was flushed with 4–5 ml PBS + 
1% FBS + 2 mM EDTA. After centrifugation, cells were resus-
pended in RPMI medium supplemented with 4 mM L-glutamine, 
100 units/ml penicillin, 100 μg/ml streptomycin and 10% heat 
inactivated FBS and subjected to fluorescence activated cell 
sorting.
Flow cytometry
Single-cell suspensions were Fc-receptor-blocked for 30 min 
at 4°C with rat anti-mouse CD16/CD32 antibody in PBS with 
1% FBS. Blocked cells were subsequently incubated with 
fluorophore-conjugated surface-staining primary antibodies for 
60 min at 4°C, prior to washing in PBS containing 1% FBS and 
2 mM EDTA. Following surface staining, cells were washed 
and analysed using a Canto II flow cytometer and FlowJo soft-
ware version 10.0. Raw data for flow cytometry analysis are 
available, see Underlying data18.
Fluorescence activated cell sorting
Following isolation from the spleen and peritoneal cavity as 
described above, cells were stained for the Mϕ lineage marker, 
F4/80 and viability dye DAPI, under sterile conditions. Briefly, 
cells were pelleted and incubated sequentially with 1:100 
Fc-receptor block for 10 min at 4°C, followed by Mϕ marker 
F4/80 antibody (1:200) and Siglec-F PE antibody (1:200) for 
30 min at 4°C. Cells were washed and sorted into F4/80 APC- 
high-expressing single positive populations on a BD InfluxTM 
cell sorter into RPMI media containing 20% FBS. Sorted cells 
were pelleted and processed for proteomics.
Urea assay
Magnetically sorted PM were seeded at 0.25 × 106 cells per 
well (96-well) in HBSS with 0.5 μM retinoic acid 20 ng/ml 
M-CSF and incubated for 2 h. The medium was removed and 
replaced with HBSS with 0.1% BSA with or without 2 mM 
glutamine and glutamate (+ 0.5 μM retinoic acid, + 20 ng/ml 
M-CSF), with or without 25 mM glucose. For urea measure-
ments, the supernatant was transferred to fresh 96-well plate after 
overnight incubation and urea levels were measured using 
a QuantiChromTM Urea Assay Kit. Raw data for urea 
quantification are available, see Underlying data18.
Filter-aided sample preparation (FASP) of samples
A total of n=4 biological replicates for PM and n=3 
biological replicates for SRPM were processed for proteomic 
analysis. Cell pellets were solubilised in 100 mM Tris HCl 
containing 4% SDS, and 100 mM dithiothreitol in the presence 
of protease and phosphatase inhibitors. Samples were proc-
essed using the FASP protocol19 with some modifications. After 
removal of SDS with 8 M urea and alkylation with iodoace-
tic acid, Vivacon 500, 10k MWCO HY filters (Sartorius Stedim 
Biotech, VN01H22) were washed three times with 100 mM 
Tris-HCl pH 8 then another four times with 100 mM triethyl 
ammonium bicarbonate (TEAB). Proteins on the filters were then 
digested twice at 30°C with trypsin (Pierce) (2 x 2 μg), first 
overnight and then for another 6 h in a final volume of 200 μl, 
100 mM TEAB. The resulting tryptic peptides were desalted 
using C18 solid phase extraction cartridges (Empore, Agilent 
technologies) and quantified using the Pierce Quantitative 
Colorimetric Peptide Assay (Thermo Scientific). Raw data for 
peptide quantification are available, see Underlying data18.
High pH reverse phase fractionation
Peptides (8 μg for each sample) were dissolved in 200 μL 
ammonium formate (10 mM, pH 9.5) and fractionated using 
RP-High pH HPLC. A C18 Column from Waters (XBridge pep-
tide BEH, 130Å, 3.5 μm 2.1 X 150 mm, Ireland) with a guard 
column (XBridge, C18, 3.5 μm, 2.1X10mm, Waters) are used 
on a Ultimate 3000 HPLC (Thermo-Scientific). Buffers A and B 
used for fractionation consist, respectively, of 10 mM ammo-
nium formate in milliQ water and 10 mM ammonium formate 
with 90% acetonitrile. Both buffers were adjusted to pH 9.5 
with ammonia. Fractions were collected using a WPS-3000FC 
auto-sampler (Thermo-Scientific) at 1 min intervals. Column and 
guard column were equilibrated with 2% buffer B for 20 min 
at a constant flow rate of 0.2 ml/min. Samples (180 μl) were 
loaded onto the column at 0.2 ml/min, and separation gradient 
start 1 min after sample loading onto the column. Peptides were 
eluted from the column with a gradient of 2% to 5% buffer B 
over 6 min and then from 5% to 60% buffer B over 53 min. The 
column was washed for 16 min in 100% buffer B and equili-
brated in 2% buffer B for 20 min as mentioned above. Fraction 
collection began 1 min after injection and stopped after 80 min 
(total of 80 fractions, 200 μl each). The total number of frac-
tions concatenated was set to 10 and the content of the fractions 
was dried and suspended in 50 μl 1% formic acid prior to 
analysis with LC-MS.
LC-MS analysis
Analysis of peptides was performed on a Velos-Pro (Thermo 
Scientific) mass spectrometer coupled with a Dionex Ultimate 
3000 RS (Thermo Scientific). LC buffers were the following: 
buffer A (2% acetonitrile and 0.1% formic acid in Milli-Q water 
(v/v)) and buffer B (80% acetonitrile and 0.08% formic acid in 
Milli-Q water (v/v). Aliquots of 15 μL of each sample were 
loaded at 5 μL/min onto a trap column (100 μm × 2 cm, PepMap 
nanoViper C18 column, 5 μm, 100 Å, Thermo Scientific) 
equilibrated in 98% buffer A. The trap column was washed 
for 6 min at the same flow rate and then the trap column was 
switched in-line with a Thermo Scientific, resolving C18 
column (75 μm × 50 cm, PepMap RSLC C18 column, 2 μm, 
100 Å). The peptides were eluted from the column at a constant 
flow rate of 300 nl/min with a linear gradient from 5% buffer B 
to 35% buffer B in 124 min, and then to 98% buffer B by 
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126 min. The column was then washed with 98% buffer B 
for 20 min and re-equilibrated in 98% buffer A for 17 min. 
Fractions (10) from each sample were analysed using LTQ- 
Orbitap Velos Pro in data dependent mode. A scan cycle com-
prised MS1 scan (m/z range from 335–1800) in the Velos orbitrap 
followed by 15 sequential dependent MS2 scans (the threshold 
value was set at 5000 and the minimum injection time was 
set at 200 ms) in LTQ with collision induced dissociation (CID). 
The resolution of the Orbitrap Velos was set at to 60,000. To 
ensure mass accuracy, the mass spectrometer was calibrated 
on the first day that the runs were started.
Proteomics quantification and bioinformatics analysis
A total of n=4 biological replicates for PM and n=3 biological 
replicates for splenic red pulp Mϕs were subjected to pro-
teomic analysis. The raw mass spectrometric data were proc-
essed, searched and quantified using MaxQuant 1.5.5.120 and 
Andromeda as the search engine software21. Enzyme specificity 
was set to that of trypsin/P, allowing for cleavage of N-terminal 
to proline residues and between aspartic acid and proline residues. 
Other parameters used were: variable modifications- methionine 
oxidation, protein N-acetylation; fixed modifications, cysteine 
carbamidomethylation; database: Uniprot - mouse; minimum 
peptide length, 7; maximum missed cleavages, 2; PSM & protein 
false discovery rate, 1%. Default MaxQuant settings included a 
mass tolerance of 7 ppm for precursor ions, and a tolerance 
of 0.5 Da for fragment ions. A reverse database was used to 
apply a maximum false positive rate of 1% for both peptide and 
protein identification. This cut-off was applied to individual 
spectra and whole proteins in the MaxQuant output. The match 
between runs feature was activated with default settings. For 
bioinformatic and statistical analysis, Perseus software (version 
1.5.1.6) was used, all ‘Contaminant’, ‘Reverse’ & ‘Only iden-
tified by site’ proteins were removed from the data and the pro-
teomic ruler5 was used to calculate copy number per cell. Proteins 
above 2-fold change [log2(2)=1], proteins with nominal 
p-value less than 0.05 [-log10(0.05)=1.301] were considered as 
differentially expressed proteins. All bioinformatics, statistical 
and pathway analyses were performed with the Perseus 
software20–22 and Excel was used for basic data analysis and 
plots. The proteome and the ImmGen mRNA data were merged 
using R studio based on GeneID. Proteomics data are available 
via ProteomeXchange with identifier PXD019362.
Statistical analysis
Statistical significance was determined using the two-tailed 
Student’s t-test. All experiments were performed at least twice. 
P values of <0.05 were considered significant. GraphPad prism 
version 6 or Perseus version 1.5.1.6 were used.
Results and Discussion
Label-free quantitative proteomics experiments were per-
formed to identify differentially regulated proteins in SRPM and 
PM that might give insights into their tissue-specific functions 
under steady-state conditions. Following tissue isolation and 
cell sorting by flow cytometry, Mϕ populations were around 
95% pure (Figure 1A). Database searches enabled the identifica-
tion of more than 7000 protein groups in these cells (Extended 
data, Table 1)18. Label-free quantitative intensity of the pro-
teins obtained using MaxQuant software followed a normal 
distribution for both the SRPM and PM populations23 
(Figure 1C). The intensities were transformed into absolute 
quantification of copy number per cell, using the proteomic 
ruler methodology5. Copy numbers for proteins from the 3 
(SRPM) or 4 (PM) biological replicates showed strong Pearson 
correlation coefficients. Variability within replicates for a sin-
gle population was from 0.968 + 0.0005 for SRPM to 0.985 + 
0.002 for PM, indicating robustness and reproducibility of our 
MS-based peptide quantification methods (Figure 1D). Princi-
pal component analysis (PCA) of all proteins expressed by the 
two sorted populations revealed a relatively greater distance 
between the SRPM and PM (Figure 1E). Volcano plots showing 
the distribution of fold-change versus p-values were gener-
ated by plotting the t-test p-value against the PM:SRPM ratio of 
copy number per cell on a logarithmic scale.
We observed a large number of protein IDs that are 
differentially regulated between the two populations of Mϕs. 
However, for many proteins, the fold increase obtained using 
copy number per cell correlated with the increase in cell size/ 
volume determined by forward scatter properties in flow cytom-
etry (Figure 1B, F, upper panel). It has previously been noted 
that PM are larger in size and volume than the SRPM24. To 
avoid the bias that enriched proteins in the PM are due to this 
increased cell size, in addition to evaluating differentially regu-
lated proteins using absolute copy number, we also evaluated 
them following normalisation, centring the median across 
samples (Figure 1F, lower panel)25. We used a fold-change of 
≥2 and p values of ≤0.05 to define differential regulation across 
biological replicates. Several proteins were differentially 
expressed by at least 2-fold when SRPM were compared to PM. 
Overall, these comparisons indicate minimum variability within 
replicates for a single population and a noticeable diversity 
between PM and SRPM populations.
Correlation analysis of mRNA and protein abundance
Integrating multiple levels of information is necessary and valu-
able to fully elucidate complex biological systems26–28. In line 
with this, we integrated our proteomic data sets with the cor-
responding mRNA data sets from the ImmGen database 
(http://rstats.immgen.org/DataPage, GSE15907, Extended data, 
Table 2)18. This allowed us to gain global understanding of 
mRNA and protein expression relationships and to iden-
tify differentially regulated proteins that are not evident at the 
transcriptomic level. Further, this integration of heterogeneous 
data sets, taken from different laboratories and across experimen-
tal platforms, has provided high-throughput data validation and 
effective use of the data to gain insights into complex biological 
functions of tissue Mϕ populations.
Out of 7533 unique proteins from our proteome data set, 
we identified 6903 corresponding transcripts from the Imm-
Gen database and used these for correlation analyses (Extended 
data, Table 3)18. The results show moderate positive correla-
tions between mRNA and protein abundance for both Mϕ popu-
lations (Figure 2A, B). As observed in other studies, improved 
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Figure 1. Peritoneal cavity and splenic red pulp macrophage proteomes. (A) Schematic overview of procedures used to isolate SRPM and 
PM (upper panel) and flow cytometry dot plots showing purities of SRPM and PM post FACS (lower panel). (B) Flow cytometry plots showing 
difference in cell size for the F4/80 positive Mϕs gated in peritoneal and splenic cell populations. (C) Histogram displaying the distribution 
of log2-transformed LFQ intensities of indicated samples. (D) Scatter plots of estimated protein copy numbers using the proteomic ruler 
approach show high correlation for biological replicates as indicated by the coefficient of determination being close to 1. (E) PCA scores 
plot showing clustering of proteins according to tissue specific Mϕ samples. (F) Volcano plots showing fold changes in proteins using copy 
number vs. log-transformed P-values from mass spectrometry analysis of PM and SRPM proteomes. Lower panel shows normalization, 
centering on the median. Four biological replicates for PM and three biological replicates for SRPM were used.
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Figure 2. Correlation between the transcriptome and the proteome. Scatter plots based on mean protein copy number for the proteome 
data set and mean fluorescence for the mRNA data set. (A) Correlation of protein vs mRNA for PM data sets; (B) correlation of protein vs 
mRNA for SRPM data sets; (C) correlation of PM mRNA vs SRPM mRNA and (D) correlation of PM proteins vs SRPM proteins from the 
proteome data. (E, F, G) Scatter plots of fold changes obtained using mRNA data vs fold changes obtained using proteome data. The 
coloured dots indicate differentially expressed genes that were statistically significant in the mRNA data set (E), protein data set (F), or 
both (G). The proteomics data were derived from 4 (PM) or 3 (SRPM) biological replicates. The mRNA data were derived from 3 biological 
replicates for each Mϕ population.
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correlations were observed when PM mRNA was compared 
with SRPM mRNA or when the PM proteome was correlated 
with the SRPM proteome (Figure 2, D)29. This can be explained 
in part by fundamental limitations and differences in transcript 
and protein behaviour, with mRNA half-life ranging from 0.1 
to ~40 h versus protein half-life 0.5 to >500 h30,31. On the one 
hand, when a target protein reaches saturating levels, gene 
silencing or transcript degradation pathways may predominate, 
leading to an inverse or moderate correlation. On the other 
hand, when a target protein is in demand in the cell, protein 
synthesis and mRNA expression may display a strong correlation.
Next, we asked whether transcripts that showed tissue- 
specific enrichment, based on ImmGen microarray analysis, were 
similarly enriched at the protein level. The mRNA data set has 
1537 unique transcripts that are differentially and significantly 
regulated (Figure 2E), compared to 3697 unique proteins in the 
proteomic dataset (Figure 2F). Correlation analysis showed that 
930 distinct transcripts (that have tissue-specific enrichment) 
were positively correlated with their corresponding proteins from 
the proteome data set (Figure 2G and Extended data, Table 4)18. 
However, we noticed that more than 35% of the differentially 
regulated transcripts were not correlated. This may be due to 
fundamental biological differences in transcript and protein 
behaviour or regulatory programs as discussed above, as well as 
variability associated with the global measurement of transcripts 
and proteins, such as differences in sensitivity, dynamic range, 
with the proteome being more dynamic (Figure 2A, B: X axis, 
proteome; Y axis, mRNA). In conclusion, our correlation of 
mRNA and protein abundance provides cross-platform/laboratory 
comparisons and high throughput validation for the transla-
tion of mRNA to protein for many of the differentially expressed 
genes. This correlation analysis also identified numerous exam-
ples of mismatches between mRNA and protein expression. 
The proteomes have thus provided many additional novel 
insights concerning the biology of these Mϕ populations not 
observed at the mRNA level.
Characterization and validation of common and tissue 
specific membrane proteins: novel insights not evident 
from the transcriptome
Cell surface proteins play a critical role in sensing and respond-
ing to the tissue microenvironment and are commonly expressed 
differentially amongst leukocyte subsets. Proteomic data showed 
that the cell adhesion molecules (CAMs) VCAM1, F11R 
(JAM1), CADM1 and PECAM1 were expressed exclusively 
in SRPM, whereas ICAM2, NINJ1, BCAM, CEACAM1 and 
ALCAM were expressed specifically by PM, with the first 
two being the major adhesion receptors (Figure 3A). Adhesion 
receptor ICAM1 was expressed at similar levels in both the Mϕ 
populations.
Integrins are a large family of heterodimeric adhesion receptors 
that contain an α- and a β- subunit. The β2 integrins exhibited 
striking differential expression, with CD11b (ITGAM α-chain; 
ITGB2 β-chain) being dominant on PM, but CD11d (ITGAD 
α-chain; ITGB2 β-chain) being exclusively expressed by SRPM 
(Figure 3B). PM expressed higher levels of ITGA6 (α6-chain) 
and ITGA4 (α4-chain) which pair with β1 and either β1 or 
β7, respectively. ITGAV (αV-chain), which can pair with sev-
eral β chains, was expressed at similar levels on PM and SRPM. 
The quantitative proteomics further showed that the integrin 
α- and β-chains were in 1:1 stoichiometry in each case (inter- 
connecting arrows, Figure 3B).
Many of the adhesion molecules identified by proteomics were 
validated by flow cytometry, showing an excellent correlation 
between proteomics data and transcriptome data (Figure 3C). 
The observed tissue specific expression of CAMs and integrins 
suggest that many of these adhesion molecules have roles in 
tissue specific interactions32.
Next we assessed Mϕ expression of Toll-like receptors (TLRs), 
which play a key role in the innate immune system. The 
proteomic analysis showed enrichment of TLR2 and TLR13 in 
PM and TLR9 in SRPM. Other TLRs were expressed at similar 
levels in both tissue Mϕs (Figure 3A and Figure 4A, B). The 
proteomics data were in disagreement with the transcriptome 
data for TLR2 expression (Figure 4A), but its preferential 
expression in PM shown by proteomics was confirmed by flow 
cytometry (Figure 4B). Low expression of TLR4 in both Mϕ 
populations seen in the proteomics data was also confirmed by 
flow cytometry (Figure 4A, B).
Similarly, proteomic analysis showed clear enrichment of 
several Mϕ growth factor receptors (M-CSF-R (CSF1R) and 
GM-CSF-R (CSF2RA, B) in PM, whereas the transcript levels 
were similar for both PM and SRPM (Figure 4A). Expression 
levels of CSF1R, determined by flow cytometry, were in good 
agreement with the proteomic data (Figure 4A, B).
Similar observations were made with a number of other 
cell surface receptors (Figure 4C, D). While the proteomics 
and transcriptome data were consistent for expression levels of 
TIMD4, EMR1, CD163, CD206 and SIGLEC12, no correlation 
was seen for CD200R1, CD244, CD80, CD44, SIRP-A, CD86 
and MS4A1. As above, the flow cytometry analysis was 
consistently in agreement with the proteomics data (Figure 4D).
Further proteomic analysis identified a wide variety of cell 
surface proteins (Figure 5 and Figure 6) that are important 
for Mϕ innate immune defence. These include galectins 
(LGALS1,3,8,9/ galectins 1, 3, 8, 9), Fc receptors (FCGR2, 
FCGRT, FCGR3, FCRL1, FCGR1, FCGR4, FCER1G), purinergic 
receptors (P2RX4, P2RX7), chemokine, cytokine and growth 
factor receptors (Figure 5 and Figure 6) that are expressed 
similarly by SRPM and PM (Figure 3–Figure 6). Although 
there was considerable overlap, these tissue Mϕs express a large 
set of differentially expressed membrane proteins involved 
in recognition and immune function. Figure 7 provides a 
pictorial overview and the copy number of these membrane 
proteins for each Mϕ population with fold enrichment greater 
than log
2
3. In brief, for PM (Figure 7A), these include integrins 
and adhesion molecules (such as ITGAM, ITGA6, NINJ1, 
ICAM2, BCAM, ANTXR2 /CAM, CEACAM1), lectins (CLEC10A, 
SELP, SELPLG, COLEC12), cytokine, chemokine receptors, 
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Figure 3. Expression levels of adhesion molecules based on proteomics, transcriptomics and flow cytometry. Cell adhesion molecules 
(A) and integrins (B), showing the estimated protein copy numbers per cell using the proteomic ruler approach (upper panels) and mean 
fluorescence of corresponding mRNA data obtained from the ImmGen database (lower panels). (C) Flow cytometry was used to validate 
proteomics for selected adhesion molecules. Upper panels show protein copy numbers per cell and lower panels show fold change in mean 
fluorescence values measured by flow cytometry, comparing specific antibodies with isotype matched controls.
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Figure 4. Expression levels obtained by proteomics is in concordance with cellular expression, even for gene IDs where proteomic 
data do not correlate with transcriptome. PM and SRPM expression of Toll-like receptors and growth factor receptors (A, B), cell surface 
immunoreceptors (C, D). (A, C) Estimated protein copy number per cell (upper panel), log fold protein increase in PM versus SRPM (middle 
panels) and mean fluorescence of mRNA expression (ImmGen) (lower panels). (B, D) Flow cytometry analysis for the indicated cell surface 
proteins. Green arrowheads in (A) and (C) show the gene IDs which are not in correlation between the proteome and the transcriptome and 
validated by flow cytometry. Chart in (B) shows distribution of TLR expression in PM and SRPM.
(CSF2RA, CRLF2, CCR, IFITM3), complement and coagula-
tion factor receptors (C5AR1, CD93/C1QR, CD209B, PLAUR), 
Toll-like receptors (TLR2), scavenger receptors (MARCO, MSR1, 
CD36, STAB1, LYVE1) Purinergic receptor (P2RX1), immune-
inhibitory receptors (VISTA, CD200R1, PILRA, PTGFRN), and 
number of other multifunctional receptors (MST1R, CD300LG, 
MCEMP1, GPM6A, FGFR1, EDNRB, SRA1). Likewise, for 
SRPM (Figure 7B), these include adhesion factors such as ITGAD, 
F11R, VCAM1, CADM1, PECAM1, C-type lectins (CLEC1B, 
CLEC4N;CLEC6A, CLEC4A, CLEC12A), sialic acid binding 
receptors (SIGLEC-1, SIGLEC-12/SIGLEC-E), lipid and pep-
tide antigen presenting molecules (CD1D1, H2-AB1, H2-AA, 
H2-EB1, H2-OB, H2-M3), Toll-like receptors (TLR9), scavenger 
receptors (MRC1/CD206, CD68, CD163), a purinergic receptor 
(P2YR13), immune-inhibitory receptors (CD300A, CD300LF, 
CD274) and number of other multifunctional membrane proteins 
such as CYSTM1, AXL, CD82, MS4A1, CD79B, GFRA2, 
THY1, PDGFRB and REEP5.
Another key group of membrane proteins are the Slc and ABC 
families of transporters. These are essential for the import and 
export of many small molecules that are vital for regulation 
of metabolic processes and immune responses. Both PM and 
SRPM express a large number of these transporters in com-
mon, as shown in Figure 8. However, some are differentially 
expressed and enriched above log
2
3-fold. For PM, these include 
the ABC family transporter ABCA9 and Slc family transport-
ers SLC2A6, SLC9A3R2, SLC25A15, SLC15A2, SLC16A3, 
SLC31A1, SLC25A1, SLC25A13 and SLC25A15. For SRPM, 
these include the ABC family transporter ABCG3 and Slc family 
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Figure 5. Characterization of CD markers and membrane receptors that are common and tissue specific. Graphs show the estimated 
protein copy numbers per cell using the proteomic ruler approach for proteome data set (upper panels), log fold protein increase in PM versus 
SRPM (middle panels) and mean fluorescence of mRNA data set obtained from ImmGen (lower panels).
transporters SLC3A2, SLC29A3, SLC35F6, SLC29A1, SLC12A2, 
SLC4A1, SLC37A2, SLC45A3 and SLC40A1;FPN1. Figure 6C 
provides a pictorial overview of their localisation and functions.
These findings indicate that, while the membrane proteins of 
PM and SRPM overlap considerably, a large set of membrane 
proteins is differentially expressed by these Mϕs which are 
likely to contribute to their tissue-specific functions, as discussed 
in the next section.
Proteins important in known tissue-specific functions of 
peritoneal cavity and splenic red pulp macrophages
Although PM and SRPM have similar embryonic origins33, 
they undergo tissue-specific differentiation programmes and 
mediate distinct functions within each microenvironment. This is 
clearly reflected in the proteomic data, as discussed below.
For PM, the transcription factor GATA6 was shown to be 
key regulator that defines a tissue-specific gene expression 
programme34. We observed enrichment of GATA6 as well as 
the reported GATA6-dependent PM-specific proteins such as 
SERPINB2, SELP (CD62P), THBS1, NT5E (CD73), TGFB2 
and LTBP1 in our PM proteome (Figure 9A).
Vitamin A is required for induction of GATA6-dependent and -
independent PM-specific gene expression programmes34. For 
vitamin A (retinol) to be transcriptionally active, it needs to 
be oxidized to the biologically active metabolite, retinoic acid 
(RA)35–37. Our proteomic analysis showed that RALDH2, the 
rate-limiting enzyme in RA synthesis35,38, is highly expressed 
in PM. This suggests that PM may be capable of converting 
vitamin A to RA and that the omentum may not be required for 
this step as proposed by Okabe (Okabe 2014). Further, RA 
exerts its biological effects, primarily, through nuclear recep-
tors RARs/RXRs and the non-nuclear receptor M6P/IGF2R39–43. 
In our proteome, we observed enhanced expression of RA 
receptors such as RXRB, RXRA, RARG and IGF2R in PM 
compared to SRPM (Figure 9A).
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Figure 6. Characterization of membrane proteins that are common and tissue specific. Graphs show the estimated protein copy numbers 
per cell using the proteomic ruler approach for proteome data set (upper panels), log fold protein increase in PM versus SRPM (middle 
panels) and mean fluorescence of mRNA data set obtained from ImmGen (lower panels).
Furthermore, in the PM proteome we observed enrichment 
of proteins such as CXCL13, TGFB2 and CD44 that have 
been implicated in PM function (Figure 9A). CXCL13, is 
essential for B-1 cell (major peritoneal cavity B cell popula-
tion) migration to the peritoneal cavity44. TGF-β generated by 
PM has been implicated in B-1 cell class switching and the gen-
eration of IgA45. In addition to enrichment of TGF-β, we also 
observed enhanced expression of TGF-β-associated proteins 
such as TGFBRAP1, TGFBI in the PM proteome (Figure 9A). 
CD44 has been shown to be important for the movement of 
PM to the liver in a sterile liver injury model to facilitate 
tissue repair by phagocytosing damaged tissue14.
For SRPM, SPI-C is a key transcription factor required for 
their development following its induction by Mϕ exposure to 
heme46 (Figure 9B). Major functions of SRPM are in cap-
ture and degradation of aged erythrocytes, repair of damaged or 
infected erythrocytes and iron homeostasis. Our proteomics 
data show enrichment of TAM receptors AXL, MERTK and 
STAB2 on SRPM (Figure 9B), which are likely to be important 
for recognition of aged or damaged erythrocytes via exposed 
phosphatidylserine, leading to erythro-phagocytosis47. We 
observed enrichment of heme oxygenase 1 (HOM-1) and fer-
roportin (SLC40A1) in SRPM (Figure 9B) which are required 
for heme metabolism and the release of free iron7. We also 
observed enrichment of CD163, which is a high affinity scavenger 
receptor for hemoglobin-haptoglobin complexes48 (Figure 9B).
Splenic hematopoietic stem and progenitor cells (HSPCs) 
localize in the red pulp near the sinusoids in parafollicular 
areas49,50. VCAM1 is important for retaining HSPCs and 
in splenic myelopoiesis and was also enriched in the 
proteome of SRPM (Figure 9A).
Insights into metabolic functions of peritoneal cavity 
macrophages
An important conceptual advance in the field of Mϕ biology, 
emerging from recent studies, is that Mϕ polarisation is 
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Figure 7. Characterization of CD markers and cell surface antigens that are tissue specific. Expression of surface proteins enriched 
in PM (A) and SRPM (B). Upper panels show the estimated protein copy numbers per cell, middle panels show log fold protein increase in 
PM versus SRPM and lower panels show mean fluorescence of mRNA expression (ImmGen). (C, D) Pictorial representation and functional 
categorisation of cell surface markers expressed on PM (C) or SRPM (D).
critically supported by metabolic shifts51. Therefore, in our pro-
teomes we asked if any key metabolic enzymes are differentially 
regulated which could give insights into tissue-specific functions 
(Figure 10).
PM were enriched with enzymes related to glycolytic- 
citrate-lipogenic switch and generation of lipid second-
ary messengers. We observed enhanced expression of glucose 
transporter SLC2A6 (GLUT6/9) and key glycolytic enzymes 
(Figure 10A, B). These include HK1 (hexokinase-1), which 
traps glucose in the cell by converting it to glucose-6-phosphate; 
PFKL (ATP-dependent 6-phosphofructokinase liver type), the 
rate-limiting enzyme mediating the third step in glycolysis; 
KHK (ketohexokinase; fructokinase), the key enzyme for die-
tary fructose catabolism that bypasses the major glycolytic 
checkpoint (PFK) and converges into the glycolytic pathway. 
The enrichment of key glycolytic enzymes in PM suggests 
that these cells exhibit high rates of glycolysis (Figure 10A, B). 
Studies by others showed increased extracellular acidification 
rates (ECAR) in PM, which are indicators of glycolytic 
activity52,53. The enhanced expression of LDH (lactate dehy-
drogenase) and SLC16A3/MCT4 (Figure 8A), the lactate 
transporter54, further supports the observed increase in ECAR 
and channelling of glycolysis towards lactate production in PM. 
Lactate at physiologic concentrations has been shown to play 
a role in visceral organ homeostasis, anti-inflammatory 
responses, wound healing and also acts as fuel donor through 
generation of pyruvate (via LDH)55–60.
Furthermore, we noted that PM express high levels of ACLY 
(ATP citrate lyase), the enzyme responsible for generating 
cytosolic acetyl-CoA from citrate of the TCA cycle 
(Figure 10A, B). This suggests that pyruvate generated through 
glycolysis may be directed to alternate pathways other than 
TCA/OXPHOS, where citrate production is an end-product 
of glucose utilisation61,62. Supporting this hypothesis, previous 
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Figure 8. Characterization of SLC and ABC family transporters. Expression of SLC family transporters (A) and ABC family transporters (B) 
in PM and SRPM. Upper panels show the estimated protein copy numbers per cell, middle panels show log fold protein increase in PM versus 
SRPM and lower panels show log fold protein increase in PM versus SRPM. C: pictorial representation and functional categorisation of SLC 
and ABC family transporters on PM and SRPM.
studies with PM noted a marked difference in rates of CO
2
 pro-
duction from the 1st and 3rd carbon of pyruvate. It was noted 
that almost 60% of the [1-14C] pyruvate that was utilized 
appeared as 14CO
2
, whereas for the [3-14C] pyruvate only about 
15% of that utilized appeared as 14CO
2
. This suggests a fate for 
acetyl-CoA produced from pyruvate other than OXPHOS52,53,63. 
Although these studies on CO
2
 production were performed 
using thioglycollate-elicited PM, the ImmGen database showed 
high levels of ACLY (ATP citrate lyase) transcripts in both 
resident and thioglycollate-elicited PM.
ACLY is a key enzyme of de novo FA synthesis, as it 
generates cytosolic acetyl-CoA, an essential biosynthetic pre-
cursor for FA synthesis. In addition, the enhanced ASPA (aspar-
toacylase) levels in PM (Figure 10A, B) and availability of its 
substrate N-acetylaspartate in peritoneal fluid52,64 could pro-
vide an additional source of acetyl donor for FA synthesis 
(Francis JS, 2016). Consistent with this idea, we observed 
enrichment of the rate-limiting enzyme of FA synthesis, ACACA 
(Acetyl-CoA Carboxylase Alpha), which converts cytosolic 
acetyl-CoA to malonyl CoA (Figure 10A and B). This pathway is 
important for M2 Mϕ development, as an inhibitor of acetyl-CoA 
carboxylase (ACACA) was shown to inhibit IL-4 induced 
M2 activation65. We also observed enrichment of ELOVL5 
(fatty acid elongase 5), which catalyzes the rate-limiting reac-
tion of the long-chain fatty acid (FA) elongation cycle and is 
vital in generation of mono/poly unsaturated FAs. Thus, the PM 
proteomics data show enrichment of key enzymes related 
to the glycolytic-citrate-lipogenic pathway. This is critical in 
many cells, including tumour cells, to fulfil bioenergetic and 
synthetic requirements66. In addition, we observed increased 
expression of FA-binding proteins FABP3, FABP4 and FABP7 
which act as cytoplasmic lipid chaperones and are impor-
tant in mediating metabolic balance and coordinating FA/lipid 
trafficking and lipid-mediated signalling in cells (Figure 10A 
and B).
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Figure 9. Enrichment of proteins related to tissue-specific functions. Peritoneal cavity specific functions (A) and spleen specific functions 
(B) showing protein copy numbers for PM and SRPM. Pictorial inset in (B) summarises SRPM protein functions. Statistical analyses were 
performed using Student’s t-test. * indicates significant difference between peritoneal and SRPM (p < 0.05).
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Figure 10. Metabolic pathway proteins enriched in peritoneal cavity macrophages. (A) Upper panel shows the estimated protein copy 
numbers per cell, middle panels show log fold protein increase in PM versus SRPM and lower panels show mean fluorescence of mRNA 
expression (ImmGen). (B) Pathway for glycolytic-lipogenic switch leading to generation of lipid messengers, as described in the Results 
section. (C) Pictorial representation showing LDL/VLDL uptake, catabolism and reverse cholesterol transport. (D) Gene IDs enriched in the 
pathways for detoxification and nitrogen homeostasis. Left panel shows the integration of deaminases into the urea cycle. Right panel shows 
pathways involved in purine catabolism. All the PM-enriched gene IDs are shown in blue. (E) Urea measurements in Mϕ culture supernatant 
after overnight incubation of PM with and without glutamine + glutamate. The first two bars are without glucose and the second two bars are 
with glucose. Red asterisks in (B) and (D) show the rate-limiting steps in the biosynthetic pathways.
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FAs are essential for many aspects of cellular function. 
They not only act as a storage form of fuel, they are also impor-
tant components of the cell membrane. When partially cleaved 
from the cell membrane, they form second messengers or 
local hormones such as arachidonic acid (AA) metabolites. These 
can mediate signalling in an autocrine or paracrine manner, 
thereby regulating inflammatory and immune responses and 
other vital cellular functions. Given that we observed enrichment 
in the PM proteome of key enzymes of FA synthesis (in 
particular Elovl5 that is required for the synthesis of monoun-
saturated and polyunsaturated FAs) as well as enrichment of 
many enzymes of the AA metabolic pathway (ALOX15, LTC4S, 
ALOX5, PTGR1, PTGES), this strongly suggests a role 
of FA synthesis in lipid secondary mediator generation 
(Figure 10A, B). Consistent with this idea, previous studies have 
observed that liver tissues of Elovl5-deficient mice had reduced 
levels of AA, eicosapentaenoic acid (EPA) and docosahex-
aenoic acid (DHA), which are precursors of the AA pathway 
mediators and substrates for ALOX15, LTC4S, ALOX5, 
PTGES67,68. Amongst these, ALOX15 (15-lipo-oxygenase) is 
the most abundant and is well documented for its role in reso-
lution of inflammation via the generation of lipid mediators 
such as resolvins, protectins and maresins14,69–71. Given the 
fact that PM can be recruited to visceral organs and contribute 
to tissue repair10–15, ALOX15 expression by PM may be impor-
tant for resolution of inflammation, clearance of apoptotic cells 
and maintenance of tissue homeostasis, similar to findings made 
with Ly6Clo, CX3CR1hi Mϕs of liver and adipose tissue69,71,72.
PM were enriched with enzymes related to lipoprotein 
uptake and cholesterol metabolism. Besides de novo synthe-
sis, FAs can be acquired from extracellular sources via recep-
tor-mediated uptake. The PM proteome exhibited increased 
levels of LDL/VLDL endocytic receptors, including CD36, 
MSR1, STAB1, LDLR, LSR. PM also expressed the lipoprotein 
lipase, LPL, which catalyses hydrolysis of triglycerides from 
LDL and VLDL (Figure 10A and C). Given that PM are rela-
tively large and mobile cells, they may require contributions from 
both exogenous triacylglycerols and de novo synthesized FAs 
to meet increasing bioenergetics and demand for biosynthetic 
and lipid secondary metabolites, similar to that of M2 Mϕs65.
We also observed enrichment of a number of proteins involved 
in regulation of cholesterol levels (Figure 10A, C), such as 
APOE (apolipoprotein E), RETNLA (adipokine resistin-like 
molecule alpha), SAA3 (serum amyloid A3) and ABCA9 
(ATP-binding cassette family transporter)73–76. Gaudreault et al 
have shown that extra-hepatic sources of apoE produced by Mϕs 
play a role in lowering plasma cholesterol and providing pro-
tection against atherosclerosis77. The identification of several 
cholesterol regulating factors enriched in the PM proteome 
further supports this suggestion.
Interestingly, we observed that PM have elevated levels of 
enzymes related to nitrogen metabolism, detoxification, and 
immunoprotective function. Enzymes involved in catabolism of 
nitrogen-containing metabolites (amino acids, nucleotides and 
monoamines) and removal of toxic ammonia via the urea cycle 
were enriched in PM. These include ARG1 (arginase-1), GLS 
(glutaminase), HAL (histidase), MAOA (monoamine oxidase 
A), PADI4 (peptidylarginine deiminase type 4), GDA (guanine 
deaminase), AMPD2 (AMP deaminase 2), XDH (xanthine 
dehydrogenase) and UOX (urate oxidase) (Figure 10A, D). 
Among these, arginase-1 is the most studied enzyme in Mϕs. In 
PM it has been shown to play a role in the generation of urea78 
and in addition, we find that PM are able to utilise glutamine and 
glutamate which are rich in the peritoneum for urea generation 
(Figure 10E). This further supports the observation that fuel 
derived from glutaminolysis is exploited by PM to maintain 
the respiratory burst as suggested recently52. Arginase-1 is a 
key signature of alternatively activated Mϕs and is involved 
in a variety of immunomodulatory functions. By limiting the 
supply of L-arginine for NO synthase and by inhibiting 
inducible NO synthase activity via the generation of urea, 
arginase-1 mediates an anti-inflammatory function78–80 
(Figure 10D). Arginase-1 can also act extrinsically to sup-
press Th2 cytokine-driven inflammation via nutrient deprivation 
of L-arginine, which is required to sustain T cell responses78. 
Arginase-1 is also involved in the regulation of wound healing 
via synthesis of ornithine-proline-collagen79,80.
Further, the proteomics data showed that XDH was strongly 
elevated in PM (Figure 10A, D). XDH, in addition to its role 
in purine catabolism (conversion of hypoxanthine/xanthine 
to uric acid), has been shown to play a significant role as a 
xenobiotic-detoxifier and also as a drug-metabolizing enzyme 
due to its relaxed specificity for substrates81. PM also expressed 
high levels of UGT1A7C (UDP-glucuronosyltransferase 1-7C) 
that catalyses glucuronidation, a major pathway of xenobiotic 
biotransformation in most mammalian species, that detoxifies 
many divergent chemical classes, rendering them harmless, more 
water-soluble, and hence excretable (Figure 10A). The proteom-
ics therefore shows that PM are enriched with many proteins 
that play a significant role in nitrogen homeostasis and in 
detoxification of various endogenous and exogenous compounds.
Insights into immune functions of peritoneal cavity 
macrophages
Besides playing an important role in homeostasis, proteomics 
confirmed that PM are also well-equipped to perform impor-
tant functions in immune defence. They expressed high levels 
of complement receptors (C5AR1, C3AR1, CD93; C1QR, 
CD209B; SIGN-R1)82 and complement factors (C1R, CR1L, 
C1QB, C1QC, C1S, C4B, CFD, CFB, CFH) which provide a 
critical first-line defence against infection (Figure 11A). We 
also observed enrichment of various coagulation factors such 
as F5, F13A1, F10, F7, FN1, KNG1, PROS1, PLAUR, PLAU 
(Figure 11A)83–85. In particular, coagulation factor XIII (F13), 
which is highly enriched in PM, has been shown to take part in 
the early innate immune defence and significantly influences 
wound healing85. It limits bacterial dissemination and facili-
tates bacterial killing through their entrapment within fibrin 
networks84. In addition, a number of chemokines and immu-
nomodulatory factors, as shown in Figure 11A, were enriched 
in PM that could play an important role in PM-mediated 
defence functions.
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Figure 11. Immune defence proteins enriched in peritoneal cavity and splenic red pulp macrophages. (A) PM-enriched and (B) SRPM-
enriched. Upper panels shows the estimated protein copy numbers per cell, middle panels show log fold protein increase in PM versus SRPM 
and lower panels show mean fluorescence of mRNA expression (ImmGen). (C) Expression of MHC-II on PM and SRPM analysed by flow 
cytometry (upper panel). Lower panel is a pictorial representation of SRPM gene IDs enriched in the pathway for peptide and lipid antigen 
presentation, as described in the Results section.
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Insights into immune functions of splenic red pulp 
macrophages
For SRPM, in addition to enrichment of proteins involved in 
regulation of erythrocyte homeostasis, we observed enhanced 
expression of many proteins related to immune defence. Here 
we discuss some of the proteins that potentially play important 
functions in splenic tissue.
SRPM were enriched with proteins related to lipid and pep-
tide antigen presentation. Antigen presentation via major 
histocompatibility complex class II molecules is highly criti-
cal in adaptive immunity. The processing and presentation of 
foreign proteins into small peptide fragments bound to class II 
molecules is a dynamic process consisting of multiple steps and 
chaperones. Several of the molecules involved in this process were 
enriched in SRPM compared to PM. We found enrichment 
of H2-A, H2-E (MHC-II) the class II antigen presenting mole-
cules; H2-G (invariant chain (li/(CLIP)), the chaperone important 
in stabilising the peptide-binding groove of MHC-II/H2-DM 
that facilitates the exchange of the class II-associated invariant- 
chain peptide (CLIP) with peptides derived from exogenous 
antigens; CSTB and CSTL cathepsins, antigen-processing 
enzymes; the NFYB transcription factor that regulates MHC 
expression (Figure 11B). Flow cytometry analysis confirmed 
higher expression of MHC class II (H-2A and H-2E subclasses) 
molecules in SRPM compared to PM (Figure 11B).
We also observed enhanced expression of the non-classical class 
1b histocompatibility antigen H2-M3 (Figure 11B). H2-M3 
specifically bind to N-formylated peptides and is important in 
presenting Listeria monocytogenes and Salmonella typhimurium 
antigens to CTL86,87.
Apart from factors involved in peptide antigen presentation, we 
also found preferential expression of lipid antigen presenting 
molecule, CD1D and PLA2G15 (lysosomal phospholipase A2) 
which processes lipid antigens for presentation by CD1d88,89 
(Figure 11B).
Thus, we observed enhanced expression of both lipid and for-
eign peptide presenting MHC-II molecules and their regula-
tors in SRPM. In comparison, classical MHC class I molecules 
which present mainly endogenous peptides recognised by 
CD8+ (cytotoxic) T cells, were present at similar levels in the 
proteomes of SRPM and PM. In conclusion, the proteomics 
data suggest that SRPM may play a previously unrecognised 
role in regulation of adaptive immune responses, in addition 
to their homeostatic role in heme recycling and erythrocyte 
homeostasis.
SRPM were enriched in a number of defence proteins such 
as CTS (cathepsins), NGP (neutrophilic granule protein), MPO 
(myeloperoxidase), EPX (eosinophil peroxidase), EAR (eosi-
nophil cationic protein), GZMA (granzyme A), ELANE (neu-
trophil elastase) and LTF (lactotransferrin) (Figure 12A). 
Many of these lytic mediators are associated with granulocytes 
but are also reported to be expressed by certain tissue Mϕs 
for pathogen defence90–92. Since SRPM have been shown to 
mediate efferocytosis of granulocytes in order to regulate steady-
state granulopoiesis and HSPC trafficking93–96, it is possible 
they acquired these factors through phagocytosis of apoptotic 
granulocytes97,98. This would also be consistent with low or 
undetectable mRNA encoding some of these proteins (Figure 12). 
However, other granulocyte markers like Gr-1(Ly6G/Ly6C) (neu-
trophils) and Siglec-F (eosinophils) were not detected (Extended 
data, Table 1)18. Finally, a number of immunomodulatory 
factors shown in Figure 12A, such as TGF-B1, IL1B, IL18, 
NOS1, IGF2, PPBP, CMC4 and serpin proteases, were enriched 
in SRPM. These could be important in host defence and 
clearance of foreign particles.
Insights into metabolic functions of splenic red pulp 
macrophages
SRPM were enriched with proteins related to glycan and 
lipid degradation enzymes. A major function of SRPM is the 
uptake of aged erythrocytes. This provides a significant phago-
cytic burden that has to be rapidly catabolised. We observed 
enhanced expression of endo-lysosomal glycan degrada-
tion enzymes such as ARSB (arylsulfatase B), IDS (iduronate 
2-sulfatase), MANBA (beta-mannosidase), NPL (sialate lyase) 
(Figure 12B). Npl is a sialic acid degradation enzyme that pre-
vents sialic acids from being recycled and returning to the cell sur-
face. Given that sialic acid is an abundant sugar on erythrocytes, 
Npl and other glycan degradation enzymes are likely to be 
important for efficient catabolism of glycans on efferocytosed 
erythrocytes. We also noted enriched levels of endo-lysosomal 
lipases/exonucleases (Figure 12B) known to be involved in 
the clearance of efferocytosed particles88,89,99–101. These include 
PLBD1 (phospholipase B-like 1), ABHD6 (monoacylglycerol 
lipase), PLD3 (phospholipase D3) with both lipase and 5’ exonu-
cleases activities and PLA2G15 (lysosomal phospholipase A2) 
which plays a role in the processing and presentation of lipid 
antigens to CD1d. We also observed enrichment of LAP3 
(cytosol aminopeptidase), ACP5 (acid phosphatase 5, lysosomal), 
a tartrate-resistant acid phosphatase, which catalyses the for-
mation of ROS and participates in degradation of endocytosed 
bone matrix and in bacterial killing102. Key enzymes of beta 
oxidation were also enriched in SRPM such as ACSF2 (Acyl- 
CoA synthetase which is required to activate FA to enter 
beta oxidation) and ACADSB (mitochondrial acyl-
CoA dehydrogenase) that initiates the first step of FA 
oxidation. The enhanced expression of this degradation machin-
ery for glycans, proteins and lipids is likely to be important 
in the effective clearance of efferocytosed cells and foreign 
material by SRPM.
We identified several enzymes of lipid metabolism expressed 
preferentially in SRPM. These include phospholipases PLBD1, 
PLD3, HPGDS (hematopoietic PGD synthase) and HPGD 
(hydroxyprostaglandin dehydrogenase) (Figure 12B). HPGDS is 
the key enzyme for production of the D and J series of prosta-
noids in immune cells. PGD2 plays pro- or anti-inflammatory 
roles, where the outcome depends on the inflammatory 
milieu103–107. Though HPGDS and HPGD were found to be highly 
expressed in spleen, their tissue-specific functional significance 
is not well understood108–111. Also of note is the enrichment of 
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Figure 12. Immune defence and metabolic pathway proteins enriched in splenic red pulp macrophages. (A, B) Upper panels shows 
the estimated protein copy numbers per cell, middle panels show log fold protein increase in PM versus SRPM and lower panels show mean 
fluorescence of mRNA expression (ImmGen). Immune defence gene IDs (A) and metabolic pathway gene IDs (B) enriched in SRPM. (C), 
pictorial representation of differential nitrogen/arginine utilisation by PM and SRPM as discussed in the Results section. The PM gene IDs are 
in blue, SRPM in red.
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GGT (gamma-glutamyltransferase), a membrane-bound enzyme 
involved in the metabolism of glutathione (gamma-glutamyl- 
cysteinyl-glycine; GSH) which can convert leukotriene C4 
to leukotriene D4.
Other metabolic pathway enzymes that were enriched in 
SRPM with a potential role in immunomodulatory function are 
shown in Figure 12B with their absolute copy numbers, fold-
change and mRNA levels. ADA (adenosine deaminase) was 
first identified in human spleen and is the predominant enzyme 
that converts the toxic DNA degradation product, deoxyadeno-
sine to the non-toxic deoxyinosine. Elevated extracellular ADA 
activity has been observed in Mϕ-rich tissues, such as liver 
and spleen and shown to be important for acute and protracted 
inflammatory responses112,113. TGM1, TGM2 (transglutami-
nase) is a multi-functional enzyme that catalyses formation of 
isopeptide bonds between lysine and glutamine and produces 
protein-protein cross-links. In the context of immune defence, 
transglutaminases are required for migration of Mϕs towards 
apoptotic cells and for phagocytosis of apoptotic bodies. They 
also prevent the release of the pro-inflammatory cell content 
by crosslinking proteins of apoptotic cells and play both anti- 
inflammatory and inflammatory roles114–116. CA1 and CA2 
(carbonic anhydrase 1, 2) are important enzymes involved in 
acid production. In osteoclasts, CA2 has been shown to be 
critically involved in demineralization of ectopic calcification, 
but with respect to SRPM, its function is unknown. Given that 
erythrocytes also express CA1 and CA2 and that we detected 
haemoglobin subunits in our proteome (Figure 12B and 
Extended data, Table 1)18, it is possible that SRPM obtained 
some erythrocyte proteins via phagocytosis of aged 
erythrocytes117–119. This would also be consistent with low 
or undetectable mRNA encoding these proteins (Figure 12). 
However, retention of erythrocyte proteins appears to be selec-
tive, as other erythrocyte markers like glycophorins, erythrocyte 
membrane skeleton band protein band EPB4.2 and hemo-
globin subunit-D120 were low or undetectable (Extended data, 
Table 1)18.
We observed enrichment in SRPM of non-canonical glyco-
lytic pathway enzymes ADPGK (ADP-dependent glucokinase), 
GPD1 (glycerol-3-phosphate dehydrogenase), SLC2A3 (Glut3-
glucose transporter) and SLC37A2 (G6PT) (Figure 12B). 
ADPGK catalyses noncanonical phosphorylation of glucose 
to glucose 6-phosphate using ADP as a phosphate donor and 
is highly expressed in human hematopoietic cells121–123. Studies 
with T-cells have shown that ADPGK activity resulted in a devia-
tion of glycolysis towards the glycerol-3-phosphate dehydro-
genase (GPD) shuttle, leading to increased mitochondrial ROS 
production. Given that we observed enrichment of, ADPGK, 
GPD1 and SLC2A3/GLUT3, a similar mechanism may be 
operational in SRPM124 and contribute to their host defence 
functions. Furthermore, G6PT functions in glucose recycling 
between the ER and the cytoplasm and its deficiency leads to 
defective myeloid phenotypes, displaying impaired glucose 
homeostasis, neutropenia and neutrophil dysfunction125–128. 
Thus, we observed a number of proteins enriched in the 
SRPM proteome that could play roles in acute inflammation, 
pathogen defence and clearance (Figure 12B).
Creatine synthesis requires three amino acids, methionine, 
glycine, and arginine, and two enzymes, GATM (glycine amidi-
notransferase) and GAMT (guanidinoacetate N-methyltransferase). 
GATM is the rate limiting step in creatine synthesis, that 
catalyses the transfer of an amidino group from L-arginine to 
glycine to generate guanidinoacetate (GAA) and GAMT methyl-
ates guanidinoacetate (the immediate precursor of creatine) to 
produce creatine.
We observed elevated levels of GATM in the SRPM proteome 
and GAMT in the PM proteome (green arrowhead in Figure 10A, 
Figure 12B and 12C). Previous studies have shown the 
requirement of two organs for completion of creatine 
synthesis129–131. In the rat, high levels of GATM are found in 
the kidney, whereas GAMT is present in the liver. Rat hepato-
cytes were found to readily convert GAA to creatine; the same 
hepatocytes were unable to produce creatine from methionine, 
arginine, and glycine. 15N from 15NH
4
Cl is readily incorporated 
into urea but not into creatine, suggesting the liver mainly uti-
lises nitrogen in arginine for urea generation via the urea cycle 
and not for creatine synthesis130,131. Similar to hepatocytes, we 
found that PM have high levels of GAMT and not the first rate- 
limiting enzyme, GATM (last column, green arrowhead in 
Figure 10A, Figure 12B and 12C). Given that PM express high 
levels of arginine, they may channel the nitrogen in arginine 
for urea generation via the urea cycle and not for creatine 
synthesis, similar to the observations made with hepatocytes 
(Figure 12C). We hypothesise that, similar to the observations 
with kidney and liver, SRPM and PM may be coordinated for 
completion of creatine synthesis.
In general terms, SRPM appear to be functionally similar to 
a population of Mϕ recently described in human liver termed 
‘Non-inflammatory Macs -cluster 10’ in single cell RNA-Seq 
data132 and Kupffer cells of the mouse. All of these cells express 
high levels of VCAM1, SLC40A1, HMOX1, CD163, AXL, 
MERTK and play roles in the capture and breakdown of aged 
erythrocytes passing through the sinusoids132–134. In comparison, 
PM appear to share some of the functions of liver hepatocytes, 
with both cells expressing high levels of enzymes ARG1, HAL, 
GAMT, PFK-1, HK1 and SAA3 which play roles in metabolism 
of nitrogen-containing compounds, carbohydrates and lipids78,132.
In conclusion, the present study provides a comprehensive view 
of the cellular profiling of Mϕs in different immune microen-
vironments and highlights the possible contributions of SRPM 
and PM populations in homeostasis and host defence that are 
adapted to each tissue environment.
Conclusions
This study has made effective use of a vast proteomic data 
set to obtain a better overall picture and understanding of the 
steady-state roles of splenic red pulp and peritoneal cavity Mϕs, 
defined mainly in terms of cell surface phenotype, metabolic 
pathways and immune functions (Figure 13). Given that several 
previous studies have demonstrated a low correlation between 
mRNA and protein expression, our proteomics analysis provides 
global profiling of these tissue Mϕs at a protein level, providing 
novel information on absolute copy number per cell. In addition, 
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Figure 13. Pictorial representation of tissue specific pathways and functions enriched in PM (A) and SRPM (B), as discussed in the Results 
section.
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the integration of our proteomics data sets with corresponding 
ImmGen transcriptomics data sets provides information on 
the relationships between the levels of transcripts and the pro-
teins that they encode. This has not been examined previously 
in a comprehensive manner for tissue Mϕs. By merging these 
heterogeneous data sets we provide high-throughput data 
validation for the translation of mRNA to protein for many of 
the differentially expressed genes. We also show for the genes 
where mRNA and protein expression do not correlate, the cellular 
expression levels (as validated by flow cytometry) were in excel-
lent agreement with the proteomics data. Thus, using quantita-
tive proteomics, we have identified and validated several novel 
cellular differences between splenic and peritoneal Mϕs which 
were not addressed previously through transcriptomics studies.
We believe our characterization of cell surface markers, 
metabolic pathways and immune functions for PM and SRPM 
will be a useful resource in the Mϕ field. In particular, peritoneal 
Mϕs are easy to isolate and have therefore been used exten-
sively as a model to study tissue Mϕ cell biology and immune 
functions. The availability of a comprehensive database of pro-
teins expressed by these Mϕs and their relative abundance is 
important as it can help interpretations of complex results 
and provide guidance as to the suitability of these Mϕ for address-
ing specific scientific questions. Dissecting the cellular compo-
nents and attempting to address why specific components are 
active at the cellular level using expression data and contex-
tual information helps to understand their possible contribution 
to tissue specific functions. For example, many of the key 
enzymes that play roles in the catabolism of dietary fructose, 
carbohydrate and proteins and the removal of toxic ammonia 
(from excess amino acids and nitrogen catabolism) via the urea 
cycle, are enriched in peritoneal Mϕs. As predicted by these 
observations, we demonstrated that peritoneal Mϕs were able 
to effectively utilise glutamine and generate urea.
Thus, our approach, which builds upon connecting the mRNA 
expression data and protein networks, along with concepts 
proposed from previous publications of target genes, may pave 
the way to understanding the biological implications of the mas-
sive data available at both the mRNA and protein levels. In 




ProteomeXchange: Towards understanding tissue Mϕ hetero-
geneity and functions using quantitative proteomics. Accession 
number PXD019362; https://identifiers.org/px:PXD019362.
Mass spectrometry proteomics data are deposited with the Pro-
teomeXchange Consortium via the PRIDE135 partner repository.
Figshare: Towards understanding the cell surface phenotype, 
metabolic properties and immune functions of resident 
macrophages of the peritoneal cavity and splenic red pulp using 
high resolution quantitative proteomics. https://doi.org/10.6084/
m9.figshare.c.5043488.v118.
This project contains the following underlying data: 
•    Data containing raw values for peptide quantification 
(XLSX) following FASP for use in MS.
•    Data containing raw values for the urea assay (XLSX).
•    The raw output values for FACS analysis (FCS) and 
the details of the experiments and linked files (PPT)
Extended data
Figshare: Towards understanding the cell surface phenotype, 
metabolic properties and immune functions of resident macro-
phages of the peritoneal cavity and splenic red pulp using high 
resolution quantitative proteomics. https://doi.org/10.6084/m9. 
figshare.c.5043488.v118.
This project contains the following extended data: 
•    Table 1. Proteomics data set. The table contains protein 
identifications and quantifications for peritoneal cavity 
Mϕ (PM) and splenic red pulp Mϕ (SM) obtained 
using proteomic analysis. The column headers describe 
the data in each column. The table also reports the copy 
number per cell for each experimental replicate obtained 
using the proteomic ruler quantifications and the rela-
tive fold change calculated using Perseus software as 
indicated in Methods.
•    Table 2. mRNA data set. The table contains gene- 
expression profiles for peritoneal and splenic Mϕs 
obtained from the ImmGen dataset. The table contains 
mRNA profile data, their mean fluorescence intensities and 
the relative fold changes wherein affymetrix microarrays 
were used as the data collection platform. The column 
headers provide descriptions of the data contained within 
the table.
•    Table 3. Proteome and mRNA data sets combined. The 
table contains protein quantification from the proteome 
dataset together with the corresponding transcripts from 
the ImmGen database which were used for the correlation 
analysis.
•    Table 4. Tissue-specific enriched proteins where 
proteome and mRNA data were positively correlated. 
The table contains protein identifications where the cor-
relation analysis showed 930 distinct transcripts with 
tissue-specific enrichment that were positively correlated 
with their corresponding proteins from the proteome 
data set.
Data hosted with Figshare are available under the terms of the 
Creative Commons Zero “No rights reserved” data waiver 
(CC0 1.0 Public domain dedication).
Page 23 of 31
Wellcome Open Research 2020, 5:165 Last updated: 12 MAY 2021
Acknowledgments
We are grateful to the staff in our animal facility for their 
help in routine breeding and maintenance of mice. We would 
like to acknowledge the assistance of Abdel Atrih and others in 
the University of Dundee Proteomics Facility. We also thank 
the Flow Cytometry and Cell Sorting Facility at the University 
of Dundee for their assistance. Help from Iain Phair and Sarah 
Thomson with peritoneal Mϕ isolation in the initial stages 
of this project is gratefully acknowledged. This work benefitted 
from data assembled by the ImmGen consortium.
References
1. T'Jonck W, Guilliams M, Bonnardel J: Niche signals and transcription factors 
involved in tissue-resident macrophage development. Cell Immunol. 2018; 330: 
43–53.  
PubMed Abstract | Publisher Full Text | Free Full Text 
2. Haldar M, Murphy KM: Origin, development, and homeostasis of tissue-resident 
macrophages. Immunol Rev. 2014; 262(1): 25–35.  
PubMed Abstract | Publisher Full Text | Free Full Text 
3. Zhou D, Yang K, Chen L, et al.: Promising landscape for regulating macrophage 
polarization: epigenetic viewpoint. Oncotarget. 2017; 8(34): 57693–57706.  
PubMed Abstract | Publisher Full Text | Free Full Text 
4. Ivashkiv LB: Epigenetic regulation of macrophage polarization and function. 
Trends Immunol. 2013; 34(5): 216–223.  
PubMed Abstract | Publisher Full Text | Free Full Text 
5. Wisniewski JR, Hein MY, Cox J, et al.: A “proteomic ruler” for protein copy 
number and concentration estimation without spike-in standards. Mol Cell 
Proteomics. 2014; 13(12): 3497–3506.  
PubMed Abstract | Publisher Full Text | Free Full Text 
6. Zhang N, Czepielewski RS, Jarjour NN, et al.: Expression of factor V by resident 
macrophages boosts host defense in the peritoneal cavity. J Exp Med. 2019; 
216(6): 1291–1300.  
PubMed Abstract | Publisher Full Text | Free Full Text 
7. Kovtunovych G, Eckhaus MA, Ghosh MC, et al.: Dysfunction of the heme 
recycling system in heme oxygenase 1-deficient mice: effects on macrophage 
viability and tissue iron distribution. Blood. 2010; 116(26): 6054–6062.  
PubMed Abstract | Publisher Full Text | Free Full Text 
8. Kohyama M, Ise W, Edelson BT, et al.: Role for Spi-C in the development of red 
pulp macrophages and splenic iron homeostasis. Nature. 2009; 457(7227): 
318–321.  
PubMed Abstract | Publisher Full Text | Free Full Text 
9. Klei TR, Meinderts SM, van den Berg TK, et al.: From the Cradle to the Grave: 
The Role of Macrophages in Erythropoiesis and Erythrophagocytosis. Front 
Immunol. 2017; 8: 73.  
PubMed Abstract | Publisher Full Text | Free Full Text 
10. Cosin-Roger J, Ortiz-Masia D, Calatayud S, et al.: The activation of Wnt signaling 
by a STAT6-dependent macrophage phenotype promotes mucosal repair in 
murine IBD. Mucosal Immunol. 2016; 9(4): 986–998.  
PubMed Abstract | Publisher Full Text 
11. Fraga-Silva TF, Venturini J, de Arruda MS: Trafficking of phagocytic peritoneal 
cells in hypoinsulinemic-hyperglycemic mice with systemic candidiasis. BMC 
Infect Dis. 2013; 13: 147.  
PubMed Abstract | Publisher Full Text | Free Full Text 
12. Rehermann B: Mature peritoneal macrophages take an avascular route into the 
injured liver and promote tissue repair. Hepatology. 2017; 65(1): 376–379.  
PubMed Abstract | Publisher Full Text | Free Full Text 
13. Song L, Papaioannou G, Zhao H, et al.: The Vitamin D Receptor Regulates 
Tissue Resident Macrophage Response to Injury. Endocrinology. 2016; 157(10): 
4066–4075.  
PubMed Abstract | Publisher Full Text | Free Full Text 
14. Wang J, Kubes P: A Reservoir of Mature Cavity Macrophages that Can Rapidly 
Invade Visceral Organs to Affect Tissue Repair. Cell. 2016; 165(3): 668–678.  
PubMed Abstract | Publisher Full Text 
15. Zeng MY, Pham D, Bagaitkar J, et al.: An efferocytosis-induced, IL-4-dependent 
macrophage-iNKT cell circuit suppresses sterile inflammation and is defective 
in murine CGD. Blood. 2013; 121(17): 3473–3483.  
PubMed Abstract | Publisher Full Text | Free Full Text 
16. Heng TS, Painter MW; Immunological Genome Project, C: The Immunological 
Genome Project: networks of gene expression in immune cells. Nat Immunol. 
2008; 9(10): 1091–1094.  
PubMed Abstract | Publisher Full Text 
17. Franken L, Klein M, Spasova M, et al.: Splenic red pulp macrophages are 
intrinsically superparamagnetic and contaminate magnetic cell isolates. Sci 
Rep. 2015; 5: 12940.  
PubMed Abstract | Publisher Full Text | Free Full Text 
18. Nagala M: Towards understanding the cell surface phenotype, metabolic 
properties and immune functions of resident macrophages of the peritoneal 
cavity and splenic red pulp using high resolution quantitative proteomics. 
Collection. Figshare. 2020.  
http://www.doi.org/10.6084/m9.figshare.c.5043488.v1
19. Wisniewski JR, Zougman A, Mann M: Combination of FASP and StageTip-
based fractionation allows in-depth analysis of the hippocampal membrane 
proteome. J Proteome Res. 2009; 8(12): 5674–5678.  
PubMed Abstract | Publisher Full Text 
20. Cox J, Mann M: MaxQuant enables high peptide identification rates, 
individualized p.p.b.-range mass accuracies and proteome-wide protein 
quantification. Nat Biotechnol. 2008; 26(12): 1367–1372.  
PubMed Abstract | Publisher Full Text 
21. Cox J, Neuhauser N, Michalski A, et al.: Andromeda: a peptide search engine 
integrated into the MaxQuant environment. J Proteome Res. 2011; 10(4):  
1794–1805.  
PubMed Abstract | Publisher Full Text 
22. Tyanova S, Temu T, Cox J: The MaxQuant computational platform for mass 
spectrometry-based shotgun proteomics. Nat Protoc. 2016; 11(12): 2301–2319.  
PubMed Abstract | Publisher Full Text 
23. Hofheinz K, Kakularam KR, Adel S, et al.: Conversion of pro-inflammatory 
murine Alox5 into an anti-inflammatory 15S-lipoxygenating enzyme by 
multiple mutations of sequence determinants. Arch Biochem Biophys. 2013; 
530(1): 40–47.  
PubMed Abstract | Publisher Full Text 
24. Wang C, Yu X, Cao Q, et al.: Characterization of murine macrophages from 
bone marrow, spleen and peritoneum. BMC Immunol. 2013; 14: 6.  
PubMed Abstract | Publisher Full Text | Free Full Text 
25. Neeley ES, Kornblau SM, Coombes KR, et al.: Variable slope normalization of 
reverse phase protein arrays. Bioinformatics. 2009; 25(11): 1384–1389.  
PubMed Abstract | Publisher Full Text | Free Full Text 
26. Vogel C, Marcotte EM: Insights into the regulation of protein abundance from 
proteomic and transcriptomic analyses. Nat Rev Genet. 2012; 13(4): 227–232.  
PubMed Abstract | Publisher Full Text | Free Full Text 
27. Laurent JM, Vogel C, Kwon T, et al.: Protein abundances are more conserved 
than mRNA abundances across diverse taxa. Proteomics. 2010; 10(23):  
4209–4212.  
PubMed Abstract | Publisher Full Text | Free Full Text 
28. Waters KM, Pounds JG, Thrall BD: Data merging for integrated microarray and 
proteomic analysis. Brief Funct Genomic Proteomic. 2006; 5(4): 261–272.  
PubMed Abstract | Publisher Full Text 
29. Piras V, Tomita M, Selvarajoo K: Is central dogma a global property of cellular 
information flow? Front Physiol. 2012; 3: 439.  
PubMed Abstract | Publisher Full Text | Free Full Text 
30. Mathieson T, Franken H, Kosinski J, et al.: Systematic analysis of protein 
turnover in primary cells. Nat Commun. 2018; 9(1): 689.  
PubMed Abstract | Publisher Full Text | Free Full Text 
31. Schwanhausser B, Busse D, Li N, et al.: Global quantification of mammalian 
gene expression control. Nature. 2011; 473(7347): 337–342.  
PubMed Abstract | Publisher Full Text 
32. Ainslie MP, McNulty CA, Huynh T, et al.: Characterisation of adhesion receptors 
mediating lymphocyte adhesion to bronchial endothelium provides evidence 
for a distinct lung homing pathway. Thorax. 2002; 57(12): 1054–1059.  
PubMed Abstract | Publisher Full Text | Free Full Text 
33. Varol C, Mildner A, Jung S: Macrophages: development and tissue 
specialization. Annu Rev Immunol. 2015; 33: 643–675.  
PubMed Abstract | Publisher Full Text 
34. Okabe Y, Medzhitov R: Tissue-specific signals control reversible program of 
localization and functional polarization of macrophages. Cell. 2014; 157(4): 
832–844.  
PubMed Abstract | Publisher Full Text | Free Full Text 
35. Gudas LJ: Emerging roles for retinoids in regeneration and differentiation in 
normal and disease states. Biochim Biophys Acta. 2012; 1821(1): 213–221.  
PubMed Abstract | Publisher Full Text | Free Full Text 
36. Kashyap V, Laursen KB, Brenet F, et al.: RARgamma is essential for retinoic 
acid induced chromatin remodeling and transcriptional activation in 
embryonic stem cells. J Cell Sci. 2013; 126(Pt 4): 999–1008.  
PubMed Abstract | Publisher Full Text | Free Full Text 
Page 24 of 31
Wellcome Open Research 2020, 5:165 Last updated: 12 MAY 2021
37. Duester G: Retinoic acid synthesis and signaling during early organogenesis. 
Cell. 2008; 134(6): 921–931.  
PubMed Abstract | Publisher Full Text | Free Full Text 
38. Blomhoff R, Green MH, Green JB, et al.: Vitamin A metabolism: new 
perspectives on absorption, transport, and storage. Physiol Rev. 1991; 71(4): 
951–990.  
PubMed Abstract | Publisher Full Text 
39. Kang JX, Li Y, Leaf A: Mannose-6-phosphate/insulin-like growth factor-II 
receptor is a receptor for retinoic acid. Proc Natl Acad Sci U S A. 1997; 94(25): 
13671–13676.  
PubMed Abstract | Publisher Full Text | Free Full Text 
40. Kang JX, Bell J, Leaf A, et al.: Retinoic acid alters the intracellular trafficking of 
the mannose-6-phosphate/insulin-like growth factor II receptor and lysosomal 
enzymes. Proc Natl Acad Sci U S A. 1998; 95(23): 13687–13691.  
PubMed Abstract | Publisher Full Text | Free Full Text 
41. Rajawat Y, Hilioti Z, Bossis I: Retinoic acid induces autophagosome maturation 
through redistribution of the cation-independent mannose-6-phosphate 
receptor. Antioxid Redox Signal. 2011; 14(11): 2165–2177.  
PubMed Abstract | Publisher Full Text 
42. Dolle P: Developmental expression of retinoic acid receptors (RARs). Nucl 
Recept Signal. 2009; 7: e006.  
PubMed Abstract | Publisher Full Text | Free Full Text 
43. Spanjaard RA, Ikeda M, Lee PJ, et al.: Specific activation of retinoic acid 
receptors (RARs) and retinoid X receptors reveals a unique role for 
RARgamma in induction of differentiation and apoptosis of S91 melanoma 
cells. J Biol Chem. 1997; 272(30): 18990–18999.  
PubMed Abstract | Publisher Full Text 
44. Ansel KM, Harris RB, Cyster JG: CXCL13 is required for B1 cell homing, natural 
antibody production, and body cavity immunity. Immunity. 2002; 16(1): 67–76.  
PubMed Abstract | Publisher Full Text 
45. Roy B, Brennecke AM, Agarwal S, et al.: An intrinsic propensity of murine 
peritoneal B1b cells to switch to IgA in presence of TGF-beta and retinoic acid. 
PLoS One. 2013; 8(12): e82121.  
PubMed Abstract | Publisher Full Text | Free Full Text 
46. Haldar M, Kohyama M, So AY, et al.: Heme-mediated SPI-C induction promotes 
monocyte differentiation into iron-recycling macrophages. Cell. 2014; 156(6): 
1223–1234.  
PubMed Abstract | Publisher Full Text | Free Full Text 
47. Chang CF, Goods BA, Askenase MH, et al.: Erythrocyte efferocytosis modulates 
macrophages towards recovery after intracerebral hemorrhage. J Clin Invest. 
2018; 128(2): 607–624.  
PubMed Abstract | Publisher Full Text | Free Full Text 
48. Estep TN: Pharmacokinetics and mechanisms of plasma removal of 
hemoglobin-based oxygen carriers. Artif Cells Nanomed Biotechnol. 2015; 43(3): 
203–215.  
PubMed Abstract | Publisher Full Text 
49. Dutta P, Hoyer FF, Grigoryeva LS, et al.: Macrophages retain hematopoietic 
stem cells in the spleen via VCAM-1. J Exp Med. 2015; 212(4): 497–512.  
PubMed Abstract | Publisher Full Text | Free Full Text 
50. Kiel MJ, Yilmaz OH, Iwashita T, et al.: SLAM family receptors distinguish 
hematopoietic stem and progenitor cells and reveal endothelial niches for 
stem cells. Cell. 2005; 121(7): 1109–1121.  
PubMed Abstract | Publisher Full Text 
51. Saha S, Shalova IN, Biswas SK: Metabolic regulation of macrophage phenotype 
and function. Immunol Rev. 2017; 280(1): 102–111.  
PubMed Abstract | Publisher Full Text 
52. Davies LC, Rice CM, Palmieri EM, et al.: Peritoneal tissue-resident macrophages 
are metabolically poised to engage microbes using tissue-niche fuels. Nat 
Commun. 2017; 8(1): 2074.  
PubMed Abstract | Publisher Full Text | Free Full Text 
53. Newsholme P, Gordon S, Newsholme EA: Rates of utilization and fates of 
glucose, glutamine, pyruvate, fatty acids and ketone bodies by mouse 
macrophages. Biochem J. 1987; 242(3): 631–6.  
PubMed Abstract | Publisher Full Text | Free Full Text 
54. Dimmer KS, Friedrich B, Lang F, et al.: The low-affinity monocarboxylate 
transporter MCT4 is adapted to the export of lactate in highly glycolytic cells. 
Biochem J. 2000; 350 Pt 1(Pt 1): 219–27.  
PubMed Abstract | Free Full Text 
55. Hoque R, Farooq A, Ghani A, et al.: Lactate reduces liver and pancreatic injury 
in Toll-like receptor- and inflammasome-mediated inflammation via GPR81-
mediated suppression of innate immunity. Gastroenterology. 2014; 146(7): 
1763–74.  
PubMed Abstract | Publisher Full Text | Free Full Text 
56. Iraporda C, Errea A, Romanin DE, et al.: Lactate and short chain fatty acids 
produced by microbial fermentation downregulate proinflammatory responses 
in intestinal epithelial cells and myeloid cells. Immunobiology. 2015; 220(10): 
1161–9.  
PubMed Abstract | Publisher Full Text 
57. Lerch MM, Conwell DL, Mayerle J: The anti-inflammasome effect of lactate 
and the lactate GPR81-receptor in pancreatic and liver inflammation. 
Gastroenterology. 2014; 146(7): 1602–5.  
PubMed Abstract | Publisher Full Text 
58. Nasi A, Fekete T, Krishnamurthy A, et al.: Dendritic cell reprogramming by 
endogenously produced lactic acid. J Immunol. 2013; 191(6): 3090–9.  
PubMed Abstract | Publisher Full Text 
59. Peter K, Rehli M, Singer K, et al.: Lactic acid delays the inflammatory response 
of human monocytes. Biochem Biophys Res Commun. 2015; 457(3): 412–8.  
PubMed Abstract | Publisher Full Text 
60. Sun S, Li H, Chen J, et al.: Lactic Acid: No Longer an Inert and End-Product of 
Glycolysis. Physiology (Bethesda). 2017; 32(6): 453–463.  
PubMed Abstract | Publisher Full Text 
61. Costello LC, Franklin RB: A review of the important central role of altered citrate 
metabolism during the process of stem cell differentiation. J Regen Med Tissue 
Eng. 2013; 2: 1.  
PubMed Abstract | Publisher Full Text | Free Full Text 
62. Williams NC, O'Neill LAJ: A Role for the Krebs Cycle Intermediate Citrate 
in Metabolic Reprogramming in Innate Immunity and Inflammation. Front 
Immunol. 2018; 9: 141.  
PubMed Abstract | Publisher Full Text | Free Full Text 
63. Newsholme P, Newsholme EA: Rates of utilization of glucose, glutamine and 
oleate and formation of end-products by mouse peritoneal macrophages in 
culture. Biochem J. 1989; 261(1): 211–218.  
PubMed Abstract | Publisher Full Text | Free Full Text 
64. Gautier EL, Ivanov S, Williams JW, et al.: Gata6 regulates aspartoacylase 
expression in resident peritoneal macrophages and controls their survival.  
J Exp Med. 2014; 211(8): 1525–1531.  
PubMed Abstract | Publisher Full Text | Free Full Text 
65. Huang SC, Everts B, Ivanova Y, et al.: Cell-intrinsic lysosomal lipolysis is 
essential for alternative activation of macrophages. Nat Immunol. 2014; 15(9): 
846–855.  
PubMed Abstract | Publisher Full Text | Free Full Text 
66. Costello LC, Franklin RB: ‘Why do tumour cells glycolyse?’: from glycolysis 
through citrate to lipogenesis. Mol Cell Biochem. 2005; 280(1–2): 1–8.  
PubMed Abstract | Publisher Full Text | Free Full Text 
67. Moon YA, Hammer RE, Horton JD: Deletion of ELOVL5 leads to fatty liver 
through activation of SREBP-1c in mice. J Lipid Res. 2009; 50(3): 412–423.  
PubMed Abstract | Publisher Full Text | Free Full Text 
68. Wang Y, Botolin D, Christian B, et al.: Tissue-specific, nutritional, and 
developmental regulation of rat fatty acid elongases. J Lipid Res. 2005; 46(4): 
706–715.  
PubMed Abstract | Publisher Full Text | Free Full Text 
69. Kwon HJ, Kim SN, Kim YA, et al.: The contribution of arachidonate 15-
lipoxygenase in tissue macrophages to adipose tissue remodeling. Cell Death 
Dis. 2016; 7(6): e2285.  
PubMed Abstract | Publisher Full Text | Free Full Text 
70. Tian R, Zuo X, Jaoude J, et al.: ALOX15 as a suppressor of inflammation and 
cancer: Lost in the link. Prostaglandins Other Lipid Mediat. 2017; 132: 77–83.  
PubMed Abstract | Publisher Full Text | Free Full Text 
71. Uderhardt S, Herrmann M, Oskolkova OV, et al.: 12/15-lipoxygenase orchestrates 
the clearance of apoptotic cells and maintains immunologic tolerance. 
Immunity. 2012; 36(5): 834–846.  
PubMed Abstract | Publisher Full Text 
72. Yang W, Zhao X, Tao Y, et al.: Proteomic analysis reveals a protective role of 
specific macrophage subsets in liver repair. Sci Rep. 2019; 9(1): 2953.  
PubMed Abstract | Publisher Full Text | Free Full Text 
73. Hayek T, Oiknine J, Brook JG, et al.: Role of HDL apolipoprotein E in cellular 
cholesterol efflux: studies in apo E knockout transgenic mice. Biochem Biophys 
Res Commun. 1994; 205(2): 1072–1078.  
PubMed Abstract | Publisher Full Text 
74. Lee MR, Lim CJ, Lee YH, et al.: The adipokine Retnla modulates cholesterol 
homeostasis in hyperlipidemic mice. Nat Commun. 2014; 5: 4410.  
PubMed Abstract | Publisher Full Text 
75. Mahley RW, Huang Y, Weisgraber KH: Putting cholesterol in its place: apoE and 
reverse cholesterol transport. J Clin Invest. 2006; 116(5): 1226–1229.  
PubMed Abstract | Publisher Full Text | Free Full Text 
76. van der Westhuyzen DR, Cai L, de Beer MC, et al.: Serum amyloid A promotes 
cholesterol efflux mediated by scavenger receptor B-I. J Biol Chem. 2005; 
280(43): 35890–35895.  
PubMed Abstract | Publisher Full Text 
77. Gaudreault N, Kumar N, Olivas VR, et al.: Macrophage-specific apoE gene repair 
reduces diet-induced hyperlipidemia and atherosclerosis in hypomorphic 
Apoe mice. PLoS One. 2012; 7(5): e35816.  
PubMed Abstract | Publisher Full Text | Free Full Text 
78. Pesce JT, Ramalingam TR, Mentink-Kane MM, et al.: Arginase-1-expressing 
macrophages suppress Th2 cytokine-driven inflammation and fibrosis. PLoS 
Pathog. 2009; 5(4): e1000371.  
PubMed Abstract | Publisher Full Text | Free Full Text 
79. Durante W, Johnson FK, Johnson RA: Arginase: a critical regulator of nitric 
oxide synthesis and vascular function. Clin Exp Pharmacol Physiol. 2007; 34(9): 
906–911.  
PubMed Abstract | Publisher Full Text | Free Full Text 
80. Mills CD: Macrophage arginine metabolism to ornithine/urea or nitric oxide/
citrulline: a life or death issue. Crit Rev Immunol. 2001; 21(5): 399–425.  
PubMed Abstract 
81. Battelli MG, Polito L, Bortolotti M, et al.: Xanthine Oxidoreductase in Drug 
Page 25 of 31
Wellcome Open Research 2020, 5:165 Last updated: 12 MAY 2021
Metabolism: Beyond a Role as a Detoxifying Enzyme. Curr Med Chem. 2016; 
23(35): 4027–4036.  
PubMed Abstract | Publisher Full Text | Free Full Text 
82. Kang YS, Do Y, Lee HK, et al.: A dominant complement fixation pathway for 
pneumococcal polysaccharides initiated by SIGN-R1 interacting with C1q. 
Cell. 2006; 125(1): 47–58.  
PubMed Abstract | Publisher Full Text 
83. Inbal A, Dardik R: Role of coagulation factor XIII (FXIII) in angiogenesis and 
tissue repair. Pathophysiol Haemost Thromb. 2006; 35(1–2): 162–165.  
PubMed Abstract | Publisher Full Text 
84. Loof TG, Morgelin M, Johansson L, et al.: Coagulation, an ancestral serine 
protease cascade, exerts a novel function in early immune defense. Blood. 
2011; 118(9): 2589–2598.  
PubMed Abstract | Publisher Full Text 
85. Soendergaard C, Kvist PH, Seidelin JB, et al.: Tissue-regenerating functions of 
coagulation factor XIII. J Thromb Haemost. 2013; 11(5): 806–816.  
PubMed Abstract | Publisher Full Text 
86. Winther M, Holdfeldt A, Gabl M, et al.: Formylated MHC Class Ib Binding 
Peptides Activate Both Human and Mouse Neutrophils Primarily through 
Formyl Peptide Receptor 1. PLoS One. 2016; 11(12): e0167529.  
PubMed Abstract | Publisher Full Text | Free Full Text 
87. Mir SA, Sharma S: Role of MHC class Ib molecule, H2-M3 in host immunity 
against tuberculosis. Vaccine. 2013; 31(37): 3818–3825.  
PubMed Abstract | Publisher Full Text 
88. Paduraru C, Bezbradica JS, Kunte A, et al.: Role for lysosomal phospholipase 
A2 in iNKT cell-mediated CD1d recognition. Proc Natl Acad Sci U S A. 2013; 
110(13): 5097–5102.  
PubMed Abstract | Publisher Full Text | Free Full Text 
89. Shayman JA, Tesmer JJG: Lysosomal phospholipase A2. Biochim Biophys Acta 
Mol Cell Biol Lipids. 2018; 1864(6): 932–940.  
PubMed Abstract | Publisher Full Text | Free Full Text 
90. Kulkarni NS, Hollins F, Sutcliffe A, et al.: Eosinophil protein in airway 
macrophages: a novel biomarker of eosinophilic inflammation in patients with 
asthma. J Allergy Clin Immunol. 2010; 126(1): 61–69 e63. 
PubMed Abstract | Publisher Full Text | Free Full Text 
91. Dollery CM, Owen CA, Sukhova GK, et al.: Neutrophil elastase in human 
atherosclerotic plaques: production by macrophages. Circulation. 2003; 
107(22): 2829–2836.  
PubMed Abstract | Publisher Full Text 
92. Karakas M, Koenig W: Myeloperoxidase production by macrophage and risk of 
atherosclerosis. Curr Atheroscler Rep. 2012; 14(3): 277–283.  
PubMed Abstract | Publisher Full Text 
93. Gordy C, Pua H, Sempowski GD, et al.: Regulation of steady-state neutrophil 
homeostasis by macrophages. Blood. 2011; 117(2): 618–629.  
PubMed Abstract | Publisher Full Text | Free Full Text 
94. McCabe A, MacNamara KC: Macrophages: Key regulators of steady-state and 
demand-adapted hematopoiesis. Exp Hematol. 2016; 44(4): 213–222.  
PubMed Abstract | Publisher Full Text | Free Full Text 
95. Furze RC, Rankin SM: The role of the bone marrow in neutrophil clearance 
under homeostatic conditions in the mouse. FASEB J. 2008; 22(9): 3111–3119.  
PubMed Abstract | Publisher Full Text | Free Full Text 
96. Casanova-Acebes M, Pitaval C, Weiss LA, et al.: Rhythmic modulation of the 
hematopoietic niche through neutrophil clearance. Cell. 2013; 153(5):  
1025–1035.  
PubMed Abstract | Publisher Full Text | Free Full Text 
97. Gao CH, Dong HL, Tai L, et al.: Lactoferrin-Containing Immunocomplexes Drive 
the Conversion of Human Macrophages from M2- into M1-like Phenotype. Front 
Immunol. 2018; 9: 37.  
PubMed Abstract | Publisher Full Text | Free Full Text 
98. Silva MT: Macrophage phagocytosis of neutrophils at inflammatory/infectious 
foci: a cooperative mechanism in the control of infection and infectious 
inflammation. J Leukoc Biol. 2011; 89(5): 675–683.  
PubMed Abstract | Publisher Full Text 
99. Schneider BE, Behrends J, Hagens K, et al.: Lysosomal phospholipase A2: a 
novel player in host immunity to Mycobacterium tuberculosis. Eur J Immunol. 
2014; 44(8): 2394–2404.  
PubMed Abstract | Publisher Full Text 
100. Pribasig MA, Mrak I, Grabner GF, et al.: alpha/beta Hydrolase Domain-containing 
6 (ABHD6) Degrades the Late Endosomal/Lysosomal Lipid Bis(monoacylglyce
ro)phosphate. J Biol Chem. 2015; 290(50): 29869–29881.  
PubMed Abstract | Publisher Full Text | Free Full Text 
101. Gavin AL, Huang D, Huber C, et al.: PLD3 and PLD4 are single-stranded acid 
exonucleases that regulate endosomal nucleic-acid sensing. Nat Immunol. 
2018; 19(9): 942–953.  
PubMed Abstract | Publisher Full Text | Free Full Text 
102. Raisanen SR, Alatalo SL, Ylipahkala H, et al.: Macrophages overexpressing 
tartrate-resistant acid phosphatase show altered profile of free radical 
production and enhanced capacity of bacterial killing. Biochem Biophys Res 
Commun. 2005; 331(1): 120–6.  
PubMed Abstract | Publisher Full Text 
103. Trivedi SG, Newson J, Rajakariar R, et al.: Essential role for hematopoietic 
prostaglandin D2 synthase in the control of delayed type hypersensitivity. Proc 
Natl Acad Sci U S A. 2006; 103(13): 5179–84.  
PubMed Abstract | Publisher Full Text | Free Full Text 
104. Kanaoka Y, Fujimori K, Kikuno R, et al.: Structure and chromosomal localization 
of human and mouse genes for hematopoietic prostaglandin D synthase. 
Conservation of the ancestral genomic structure of sigma-class glutathione 
S-transferase. Eur J Biochem. 2000; 267(11): 3315–22.  
PubMed Abstract | Publisher Full Text 
105. Tanaka K, Ogawa K, Sugamura K, et al.: Cutting edge: differential production 
of prostaglandin D2 by human helper T cell subsets. J Immunol. 2000; 164(5): 
2277–80.  
PubMed Abstract | Publisher Full Text 
106. Mohri I, Taniike M, Taniguchi H, et al.: Prostaglandin D2-mediated microglia/
astrocyte interaction enhances astrogliosis and demyelination in twitcher.  
J Neurosci. 2006; 26(16): 4383–93.  
PubMed Abstract | Publisher Full Text | Free Full Text 
107. Mohri I, Eguchi N, Suzuki K, et al.: Hematopoietic prostaglandin D synthase is 
expressed in microglia in the developing postnatal mouse brain. Glia. 2003; 
42(3): 263–74.  
PubMed Abstract | Publisher Full Text 
108. Joo M, Sadikot RT: PGD synthase and PGD2 in immune resposne. Mediators 
Inflamm. 2012; 2012: 503128.  
PubMed Abstract | Publisher Full Text | Free Full Text 
109. Kanaoka Y, Ago H, Inagaki E, et al.: Cloning and crystal structure of 
hematopoietic prostaglandin D synthase. Cell. 1997; 90(6): 1085–95.  
PubMed Abstract | Publisher Full Text 
110. Meyer DJ, Thomas M: Characterization of rat spleen prostaglandin H D-
isomerase as a sigma-class GSH transferase. Biochem J. 1995; 311(Pt 3): 
739–42.  
PubMed Abstract | Publisher Full Text | Free Full Text 
111. Urade Y, Fujimoto N, Ujihara M, et al.: Biochemical and immunological 
characterization of rat spleen prostaglandin D synthetase. J Biol Chem. 1987; 
262(8): 3820–3825.  
PubMed Abstract 
112. Chen W, Zhang S, Zhang W, et al.: Elevated serum adenosine deaminase levels 
in secondary hemophagocytic lymphohistiocytosis. Int J Lab Hematol. 2015; 
37(4): 544–550.  
PubMed Abstract | Publisher Full Text 
113. Apasov SG, Blackburn MR, Kellems RE, et al.: Adenosine deaminase deficiency 
increases thymic apoptosis and causes defective T cell receptor signaling.  
J Clin Invest. 2001; 108(1): 131–141.  
PubMed Abstract | Publisher Full Text | Free Full Text 
114. Toth B, Garabuczi E, Sarang Z, et al.: Transglutaminase 2 is needed for the 
formation of an efficient phagocyte portal in macrophages engulfing apoptotic 
cells. J Immunol. 2009; 182(4): 2084–2092.  
PubMed Abstract | Publisher Full Text 
115. Sarang Z, Madi A, Koy C, et al.: Tissue transglutaminase (TG2) facilitates 
phosphatidylserine exposure and calpain activity in calcium-induced death of 
erythrocytes. Cell Death Differ. 2007; 14(10): 1842–1844.  
PubMed Abstract | Publisher Full Text | Free Full Text 
116. Szondy Z, Korponay-Szabo I, Kiraly R, et al.: Transglutaminase 2 in human 
diseases. Biomedicine (Taipei). 2017; 7(3): 15.  
PubMed Abstract | Publisher Full Text | Free Full Text 
117. Barinda AJ, Ikeda K, Hirata KI, et al.: Macrophages Highly Express Carbonic 
Anhydrase 2 and Play a Significant Role in Demineralization of the Ectopic 
Calcification. Kobe J Med Sci. 2017; 63(2): E45–E50.  
PubMed Abstract | Free Full Text 
118. Karhukorpi EK: Carbonic anhydrase II in rat acid secreting cells: comparison 
of osteoclasts with gastric parietal cells and kidney intercalated cells. Acta 
Histochem. 1991; 90(1): 11–20.  
PubMed Abstract | Publisher Full Text 
119. Sundquist KT, Leppilampi M, Jarvelin K, et al.: Carbonic anhydrase isoenzymes 
in isolated rat peripheral monocytes, tissue macrophages, and osteoclasts. 
Bone. 1987; 8(1): 33–38.  
PubMed Abstract | Publisher Full Text 
120. Bryk AH, Wisniewski JR: Quantitative Analysis of Human Red Blood Cell 
Proteome. J Proteome Res. 2017; 16(8): 2752–2761.  
PubMed Abstract | Publisher Full Text 
121. Grudnik P, Kaminski MM, Rembacz KP, et al.: Structural basis for ADP-
dependent glucokinase inhibition by 8-bromo-substituted adenosine 
nucleotide. J Biol Chem. 2018; 293(28): 11088–11099.  
PubMed Abstract | Publisher Full Text | Free Full Text 
122. Hruz T, Laule O, Szabo G, et al.: Genevestigator v3: a reference expression 
database for the meta-analysis of transcriptomes. Adv Bioinformatics. 2008; 
2008: 420747.  
PubMed Abstract | Publisher Full Text | Free Full Text 
123. Wu C, Orozco C, Boyer J, et al.: BioGPS: an extensible and customizable portal 
for querying and organizing gene annotation resources. Genome Biol. 2009; 
10(11): R130.  
PubMed Abstract | Publisher Full Text | Free Full Text 
124. Kaminski MM, Sauer SW, Kaminski M, et al.: T cell activation is driven by an 
ADP-dependent glucokinase linking enhanced glycolysis with mitochondrial 
reactive oxygen species generation. Cell Rep. 2012; 2(5): 1300–1315.  
PubMed Abstract | Publisher Full Text 
125. Chou JY, Mansfield BC: The SLC37 family of sugar-phosphate/phosphate 
exchangers. Curr Top Membr. 2014; 73: 357–382.  
PubMed Abstract | Publisher Full Text | Free Full Text 
Page 26 of 31
Wellcome Open Research 2020, 5:165 Last updated: 12 MAY 2021
126. Cappello AR, Curcio R, Lappano R, et al.: The Physiopathological Role of the 
Exchangers Belonging to the SLC37 Family. Front Chem. 2018; 6: 122.  
PubMed Abstract | Publisher Full Text | Free Full Text 
127. Chou JY, Cho JH, Kim GY, et al.: Molecular biology and gene therapy for 
glycogen storage disease type Ib. J Inherit Metab Dis. 2018; 41(6):  
1007–1014.  
PubMed Abstract | Publisher Full Text 
128. Lin SR, Pan CJ, Mansfield BC, et al.: Functional analysis of mutations in a 
severe congenital neutropenia syndrome caused by glucose-6-phosphatase-
beta deficiency. Mol Genet Metab. 2015; 114(1): 41–45.  
PubMed Abstract | Publisher Full Text | Free Full Text 
129. Barcelos RP, Stefanello ST, Mauriz JL, et al.: Creatine and the Liver: Metabolism 
and Possible Interactions. Mini Rev Med Chem. 2016; 16(1): 12–18.  
PubMed Abstract | Publisher Full Text 
130. da Silva RP, Nissim I, Brosnan ME, et al.: Creatine synthesis: hepatic 
metabolism of guanidinoacetate and creatine in the rat in vitro and in vivo. Am 
J Physiol Endocrinol Metab. 2009; 296(2): E256–261.  
PubMed Abstract | Publisher Full Text | Free Full Text 
131. Edison EE, Brosnan ME, Meyer C, et al.: Creatine synthesis: production of 
guanidinoacetate by the rat and human kidney in vivo. Am J Physiol Renal 
Physiol. 2007; 293(6): F1799–804.  
PubMed Abstract | Publisher Full Text 
132. MacParland SA, Liu JC, Ma XZ, et al.: Single cell RNA sequencing of human 
liver reveals distinct intrahepatic macrophage populations. Nat Commun. 2018; 
9(1): 4383.  
PubMed Abstract | Publisher Full Text | Free Full Text 
133. Li W, Wang Y, Zhao H, et al.: Identification and transcriptome analysis of 
erythroblastic island macrophages. Blood. 2019; 134(5): 480–491.  
PubMed Abstract | Publisher Full Text | Free Full Text 
134. Scott CL, Guilliams M: The role of Kupffer cells in hepatic iron and lipid 
metabolism. J Hepatol. 2018; 69(5): 1197–1199.  
PubMed Abstract | Publisher Full Text 
135. Perez-Riverol Y, Csordas A, Bai J, et al.: The PRIDE database and related tools 
and resources in 2019: improving support for quantification data. Nucleic Acids 
Res. 2019; 47(D1): D442–D450.  
PubMed Abstract | Publisher Full Text | Free Full Text 
Page 27 of 31
Wellcome Open Research 2020, 5:165 Last updated: 12 MAY 2021
Open Peer Review
Current Peer Review Status:   
Version 1
Reviewer Report 29 July 2020
https://doi.org/10.21956/wellcomeopenres.17617.r39501
© 2020 Pollard J et al. This is an open access peer review report distributed under the terms of the Creative 
Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, 
provided the original work is properly cited.
Luca Cassetta   
University of Edinburgh, Edinburgh, UK 
Jeffrey Pollard   
College of Medicine and Veterinary Medicine, University of Edinburgh, Edinburgh, EH16 4TJ, UK 
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regulated by CSF1 ligand thus the density reflects signalling to some degree.  Thus, unless 
the cells are permeabilised the comparison with mRNA levels are not justified.  Similarly, 
CSF1 is usually not made by macrophages (minimal transcripts in the paper) but is 
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found for other proteins as noted for the presence of erythrocyte proteins. This again is not 




The paper would be improved by adding more text in the figure legends and explain a bit 
better the figures. 
3. 
 
Page 28 of 31
Wellcome Open Research 2020, 5:165 Last updated: 12 MAY 2021
Example: Figure 3B, please explain in the legends the meaning of the dotted coloured lines, 
it is present in the text but figures should be self-explanatory.  
Same for figure 2A-D, there are P and S values, not explained in the fig legends. 
 
Flow cytometry experiments reported in Fig 3C and 4B and D. How many replicas were 
performed, can you run statistical  analysis on these data?
4. 
 
Is the work clearly and accurately presented and does it cite the current literature?
Yes
Is the study design appropriate and is the work technically sound?
Yes
Are sufficient details of methods and analysis provided to allow replication by others?
Yes
If applicable, is the statistical analysis and its interpretation appropriate?
Yes
Are all the source data underlying the results available to ensure full reproducibility?
Yes
Are the conclusions drawn adequately supported by the results?
Yes
Competing Interests: Both Dr Cassetta and I are co-founders in Macomics a macrophages 
immunoonclogy company. However, there are no conflicts of interest with this paper.
Reviewer Expertise: Macrophage biology
We confirm that we have read this submission and believe that we have an appropriate level 
of expertise to confirm that it is of an acceptable scientific standard.
Reviewer Report 28 July 2020
https://doi.org/10.21956/wellcomeopenres.17617.r39500
© 2020 Ginhoux F et al. This is an open access peer review report distributed under the terms of the Creative 
Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, 
provided the original work is properly cited.
Camille Bleriot  
Agency for Science, Technology and Research (A*STAR), Singapore Immunology Network (SIgN), 
Singapore, Singapore 
Florent Ginhoux  
 
Page 29 of 31
Wellcome Open Research 2020, 5:165 Last updated: 12 MAY 2021
Agency for Science, Technology and Research (A*STAR), Singapore Immunology Network (SIgN), 
Singapore, 138648, Singapore 
This report by Nagala & Crocker aims at comparing the proteome of murine splenic red pulp and 
peritoneal macrophages. Briefly, authors have sorted and profiled these two macrophage 
populations by using high-resolution quantitative proteomics to gain insights into the functions of 
these two subsets. The report constitutes a solid but simple resource for the community, 
confirming what is already published. One could argue about the relevance of the study as an 
extensive catalog of differentially expressed proteins and hypotheses concerning their biological 
functions. The flow cytometry validation is undoubtedly important here but the biological 
relevance is questionable as validation is lacking for the biological relevance of the findings. Also, 
readers could ask about the choice of the authors to have targeted these two populations. 
Basically, ones could compare one by one virtually all macrophage populations i.emicroglia vs. 
Kupffer cells or alveolar macrophages vs. heart macrophages and obtain a similar study. The 
underlying question is to decide if this kind of catalog deserves a publication in itself or if it should 
be reported as a publicly available database.  
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Figure 3C is not so relevant as data are already reported in Figures 3A and B. Similarly, there 
are often the same data reported on different panels.  
 
○
What is MF on figures 4A & B? Is it the mean fluorescence intensity recorded by flow 
cytometry? It seems to not fit with the protein expression data and the plots from figures 4B 
& D. Authors should clarify this. 
 
○
Page 11: “This suggests that PM may be capable of converting vitamin A to RA and that the 
omentum may not be required for this step as proposed by Okabe (Okabe 2014)” typo, the 
ref should be included as others.
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